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OBJECTIVES   
To assess the colonization rate and catheter related bloodstream infection rate of internal jugular 
and femoral central venous catheters in Medical Intensive Care Unit and Medical High 
Dependency Unit. 
METHODS    
Single blinded randomized controlled trial where the site of central venous catheter insertion was 
determined by randomization. There were 2 arms with equal allocation – internal jugular and femoral  
 
 
Inclusion criteria 
All patients in Medical Intensive Care Unit / Medical High Dependency Unit who require 
insertion of a central venous catheter 
 
Exclusion criteria 
A) Deep vein thrombosis  
B) Cardiac arrest in the last 24 hours 
D) Patients who do not give consent  
E) Pregnant women 
F) Immunocompromised patients  
G) Severe coagulopathy   
H) Skin lesion  
I) Profound volume overload  
 
Primary Outcome:   
Colonization rate of central venous catheter tip in the jugular and femoral group  
 
Secondary outcome:  
Catheter Related Bloodstream Infection rate in patients with jugular and femoral central venous 
catheters 
 
RESULTS    
The colonization rate in the internal jugular and the femoral group was 20.5% and 23.9% 
respectively.  This difference was not statistically significant.  More patients need to be included 
in the study to draw clinical implications.  
There were 3 catheter related bloodstream infections among the patients included in the study. 
All 3 infections were in the femoral group.  There is a trend towards higher number of catheter 
related bloodstream infections in the femoral group in spite of similar colonization rates. 
 
Keywords: catheter related bloodstream infections, catheter related bloodstream infection rate, 
colonization rate   
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INTRODUCTION 
 
Central Venous Catheter (CVC) is a catheter placed into a large vein to obtain an 
intravenous access. Its use has become indispensable in the management of critically ill 
patients. Central venous catheters are used for hemodynamic monitoring, measurement of 
Central Venous Pressure, hemodialysis / plasmapheresis and in the setting of difficult 
peripheral venous access in critically ill patients. Despite its benefits, central venous 
catheters have drawbacks as well.  Catheter insertion may result in mechanical 
complications like arterial puncture, hematoma formation, pneumothorax and  
hemothorax. Late complications include bloodstream infection and local infection due to 
the catheter. 
Earlier studies have shown that jugular and subclavian venous catheters have a lower rate 
of infectious complications as compared to femoral central venous catheters. However, 
over the years, the overall rate of catheter related bloodstream infections has declined. 
This is secondary to better compliance with sterile barrier precaution measures, better 
handling of the catheter and education of healthcare workers regarding aseptic 
precautions when handling catheters.  
Recent studies have failed to demonstrate superiority of one insertion site over the other 
with respect to infectious complications. The insertion of femoral catheters does not 
subject the patient to the risks of pneumothorax and hemothorax and can be performed by 
relatively inexperienced operators. In patients who require prolonged mechanical 
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ventilation, secretions from tracheostomy is a potential source of infection for patients 
with jugular venous catheters.  
The purpose of this study is to determine the rate of infectious complications in the 
internal jugular and the femoral site in critically ill patients. 
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AIMS  
To assess the rate of infectious complications in femoral and internal jugular central 
venous catheters in the Medical Intensive Care Unit and Medical High Dependency Unit. 
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OBJECTIVES  
To assess the colonization rate and catheter related bloodstream infection rate of internal 
jugular and femoral central venous catheters in Medical Intensive Care Unit and Medical 
High Dependency Unit. 
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REVIEW OF LITERATURE 
 
Central venous catheters, or central lines, are thin long flexible tubes that are inserted into 
one of the great veins and lie in proximity to the heart. 
Central venous catheters can be inserted through a proximal central vein commonly the 
internal jugular, subclavian or femoral vein, or through a peripheral vein. The catheter is 
threaded through the vein till the tip reaches a large vein near the heart. The tip of the 
central venous catheter resides in the right atrium, superior vena cava or the inferior vena 
cava.  
Central venous catheters are used to rapidly give medications and blood products, and for 
intravenous hydration. They are used to measure central venous pressure.  Central venous 
catheters may have up to five lumens.  
 
HISTORY 
 
The first central venous catheter insertion was done by Werner Frossman in 1929. His  
initial thoughts were ridiculed and opposed by his colleagues. He inserted a ureteric 
catheter into his own antecubital vein and threaded the catheter up to 65 cm to reach the 
right atrium. With the catheter in situ, he walked to the X-ray room and demonstrated the 
accurate position of the tip of the catheter in the right atrium. He thereby convinced his 
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colleagues of the safety of the procedure. He received Nobel Prize in Medicine in the 
year 1956 for his immense contribution in this field. (1) 
Sven-Ivar Seldinger, in the year 1953 published his pioneering technique of introducing 
catheters into body cavities. This technique had the advantage of use of thinner bore 
needles, less vessel wall damage and less risk of extravasations.  This technique is still 
the benchmark in terms of placement of the central venous lines. The use of this 
technique provides greater safety in internal jugular and subclavian vein cannulation. (2) 
It is also used in various non-vascular interventions like tumour biopsy, embolization, 
percutaneous cholangiogram and percutaneous nephrostomy.  (3)  
Central venous catheters can be associated with thrombosis, infectious complications and 
mechanical complications. An ideal central venous catheter should have ease of insertion, 
low thrombogenecity and a low rate of infectious complications. 
 
INDICATIONS: 
 
Indications for insertion of CVCs include the following: 
1) Administration of high dose of vasopressors and irritant drugs (eg. Chemotherapeutic 
agents, antibiotics, antifungals) which may cause phlebitis if administered through a 
peripheral vein 
2) Rapid administration of medications and fluids in critically ill patients 
3) Lack of peripheral venous access in a critically ill patient 
. 
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4) Total parenteral nutrition 
5) To measure central venous pressure 
6) To monitor venous oxyhemoglobin saturation 
 Central venous catheters also provide a channel for drawing blood samples without 
repeated peripheral venipunctures.   
 
CONTRAINDICATIONS: 
 
Contraindications for insertion of CVCs include the following: 
1) Deranged bleeding parameters 
2) Thrombocytopenia 
3) Vessel thrombosis or stenosis 
4) Infection overlying the insertion site 
The decision of insertion of a central venous catheter has to be made for each individual 
patient by the physician keeping in mind the potential risks involved, the expected 
duration of the catheter, as well hemodynamic stability and coagulation parameters of the 
patient.  
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The preferred site of insertion of a central venous catheter depends on various factors 
including the experience of the operator and the availability of an ultrasound for  
insertion of catheter. Patient related factors including risk of bleeding and pneumothorax 
and the urgency of placement of the central venous catheter also play a role in 
determining the site of insertion of the central venous catheter.  
 
 TYPES OF CENTRAL VENOUS CATHETERS: 
 
 
1) Tunneled versus non tunneled central venous catheters 
Tunneled central venous catheters are catheters in which the site of skin insertion is away 
from the site of entry into the vein. The catheter is tunneled through a short distance 
forming a subcutaneous tract to reach the vein. Tunneling is done for central venous 
catheters which are required for a long duration. These catheters have an additional 
Dacron cuff which lies near the exit site on the external lumen. The cuff helps in 
adherence and also acts as a barrier to cutaneous micro-organisms that may invade the 
subcutaneous tract(4). 
 In non-tunneled central venous catheters, the site of insertion is adjacent to the site of 
entry into the vein. Non tunneled central venous catheters are the preferred catheters for  
emergency and short term use. 
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2) Peripherally Inserted Central Catheters  
Peripherally inserted central venous catheters are placed in the basilic, brachial or 
cephalic veins and threaded to reach the superior vena cava. They can be used for long 
term as well as short term use. 
 
3) Single versus multi-lumen catheters  
In critically ill patients who require rapid administration of multiple drugs and continuous 
infusions, catheters with multiple lumens are preferred. 
Single lumen catheters are used in stable patients in case of inability to get peripheral 
venous access or prolonged intravenous antibiotic therapy.  
 
4) Antibiotic coated catheters: 
 
Central venous catheters can be coated with antibiotics or heparin which is thought to 
reduce infectious complications. The common antibiotics which are used for coating 
central venous catheters include a combination of chlorhexidine with silver sulfadiazine 
and minocycline with rifampin.  
 
. 
16 
 
5) Implantable ports:  
They consist of a titanium or plastic container with a central silicone partition. These 
catheters are placed in the superior vena cava. These are used for long term therapy, 
usually in patients who are receiving chemotherapy. These are surgically inserted in the 
upper chest or arm.  
 
COMPLICATIONS OF CENTRAL VENOUS CATHETERS: 
 
Complications of central venous catheters include early periprocedural complications and 
late    complications.  
 
1) Early complications can occur during central venous catheter insertion. Early 
complications include catheter misplacement, pneumothorax, hemothorax, arterial 
puncture, hematoma formation, air embolism.   
 
2) Late complications include colonization, bloodstream infection due to the 
catheter, infection of the exit site and catheter related thrombosis  
 
Central venous catheter related complications can also be classified as 
mechanical, thrombotic and infectious. 
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MECHANICAL COMPLICATIONS: 
 
Mechanical complications due to central venous catheter insertion include hematoma, 
arterial puncture or arterial cannulation, pneumothorax, hemothorax, placement failure, 
kinking of the guidewire and catheter tip malposition. Rates of mechanical complications 
range from 5 to 29% (5).  
An Indian study by Mathai et al which examined 480 central venous catheter insertions 
over a 1 year period found the rate of mechanical complications to be 17.9%. Arterial 
puncture and hematoma were more frequent with 2 or more attempts at catheter insertion. 
Internal jugular catheter insertion was associated with increased probability of 
unsuccessful attempts at catheterisation (6). The probability of arterial puncture is highest 
with femoral followed by internal jugular central venous catheters. The chance of 
hematoma formation is also highest in the femoral group.  
The possibility of pneumothorax and hemothorax occurs only in subclavian and internal 
jugular central venous catheters, the risk being higher in the subclavian group (5).   
History of surgery or radiotherapy in the past, high body mass index, previous 
catheterization, age and higher time to catheter placement have been delineated as risk 
factors for mechanical complications. The risk of mechanical complications has been 
found to be higher with more than 2 attempts and inexperienced operators. 
. 
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 The risk of pneumothorax is higher with multiple attempts at CVC insertion, emergency 
CVC insertions and a larger needle size. Failed attempt at CVC insertion is considered as 
a reliable predictor of mechanical complication. The risk of guide wire kinking is also 
increased if multiple attempts at CVC insertion are made. 
In Sznajder’s study which included 714 attempts at CVC insertion, failure rate was found 
to be significantly higher among inexperienced operators with less than 50 CVC 
insertions as compared to experienced operators (19 % versus 10 %). The rate of 
mechanical complications was 11% among experienced operators and 5% among 
inexperienced operators. (7) Central venous catheter insertion during the night has 
increased risk of mechanical complications. (8) 
The use of ultrasound guided CVC insertions enables the operator to locate the vein, 
recognize anatomical variations, and also assess the patency of the vein. (9) Ultrasound 
guided internal jugular catheterization is associated with lower likelihood of failed 
attempts at catheterization, arterial puncture and hematoma formation.  Time required for 
central venous catheter insertion is also shorter when insertion is under ultrasound 
guidance (5). In case of ultrasound guided CVC insertion, obesity and coagulopathy have 
not shown to increase the risk of mechanical complications (9) 
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THROMBOTIC COMPLICATIONS 
 
Central venous catheter related thrombosis can be clinical or subclinical.  Clinically 
manifest thrombosis is associated with symptoms and signs including swelling, warmth, 
tenderness and edema and can be detected on Doppler screening.  Subclinical thrombosis 
is detected by Doppler screening in the absence of signs and symptoms. The initial event 
is the formation of catheter sleeve  composed of fibrin and collagen which  promotes the 
formation of a thrombus. This mural thrombus can enlarge and form an occlusive 
thrombus. The thrombus is identified by non-compressibility of the vein and its direct 
visualization within the vein. The incidence of central venous catheter related thrombosis 
can be up to 28 %.  Factor V Leiden and prothrombin G20210 A are associated with 
increased risk (relative risk 2.7) of central venous catheter related thrombosis.(10)  
In a trial conducted by Rooden et al, out of 368 patients, 29% of patients had central 
venous catheter related thrombosis, of which 7 % had clinically manifest thrombosis and 
22% were asymptomatic.  The absence of anticoagulant therapy was associated with high 
risk of clinically manifest thrombosis ( relative risk 4.7).The authors concluded that 
formation of a thrombus following central venous catheter insertion is a common 
occurrence and those with risk factors are more likely to progress to the stage of 
clinically manifest thrombosis (10) 
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INFECTIOUS COMPLICATIONS 
 
Infectious complications consist of colonization, exit site infection and catheter related 
bloodstream infection.   
 
CATHETER TIP COLONIZATION: 
Catheter tip colonization is usually asymptomatic and is a precedent to catheter related 
bloodstream infection.  The predominant route of migration of micro-organisms for short 
term central venous catheters is from the insertion site via the outer catheter surface to  
the tip of the device. However, for long term central venous catheters, intraluminal 
contamination from hands of healthcare personnel is thought to be the most common 
mechanism. Rarely, haematogenous spread of organisms from a septic focus may result 
in seeding of a central line and catheter tip colonization. Semi-quantitative culture 
methods detect micro-organisms present on the outer surface of the catheter whereas 
quantitative culture methods detect intraluminal micro-organisms.  
 
MAKI’S ROLL PLATE TECHNIQUE:  
 
This is the commonly used method for central venous catheter tip cultures.  This is a 
semi-quantitative method which involves rolling the external surface of the catheter on a 
blood agar plate five times to detect the presence of micro-organisms. The colony 
forming units are counted 24 to 48 hours following incubation at 37 degrees. The central 
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venous catheter should be removed under aseptic precautions. The skin adjacent to the 
insertion site should disinfected with chlorhexidine or an alcohol based disinfectant. 5 cm 
of the catheter segment should be excised and sent for culture.    
Maki’s roll plate technique has a sensitivity and specificity of 83% and 85% respectively.  
The positive predictive value ranges from 40 to 80%. The positive predictive value 
increases with increase in the pretest probability. In a clinical setting with high pretest 
probability, in patients with fever, tenderness, redness or purulence at the catheter site, 
the positive predictive value of this technique approaches 80%.  
 However, the organisms present intraluminally cannot be cultured by this method. 
Quantitative culture methods can detect the presence of intraluminal organisms. 
Quantitative culture methods include sonication, centrifugation and vortexing. The 
sensitivity and specificity are 82% and 89–97% respectively. Direct visualization of 
micro-organisms via gram stain and acridine orange staining of the central venous 
catheter can also be done. The limitations of this method are that it is not practical for 
large number of samples and it is labour intensive. (11) 
Catheter tip colonization is defined as “growth of more than 15 colony forming units 
from a 5 cm segment of the catheter tip by semi-quantitative (roll-plate) culture or growth 
of more than 100 colony forming units from a catheter by quantitative (sonication) broth 
culture”(12) 
The roll plate technique is preferred for central venous catheter tip cultures. This 
technique has been shown to be superior to quantitative methods.  (13,14) 
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COLONIZATION AS A MARKER FOR CENTRAL LINE RELATED 
INFECTIOUS COMPLICATIONS:  
 
As colonization of the central venous catheter tip is a precedent to central line related 
bloodstream infection, CVC tip cultures are useful in the assessment of central line 
related infectious complications. In a patient suspected of having nosocomial infection, a 
positive central venous catheter tip culture provides evidence to prove that the catheter is 
the source of infection. Catheter tip culture has been shown to have good correlation with 
CRBSI and is a useful surrogate end point for the same.(15) 
For the definitive diagnosis of a catheter related bloodstream infection, the same micro- 
organism with the same species and sensitivity profile should be isolated from the 
catheter tip and peripheral blood.   Positive catheter tip culture with Staphylococcus and 
Candida in the absence of bloodstream infection should warrant further evaluation. 
Positive central venous catheter tip cultures are associated with bacteremia in 10 to 14 % 
of cases.  
A negative catheter tip culture is unlikely to be associated with bacteremia. In a clinical 
setting with low incidence of catheter related infectious complications and hence a low 
pretest probability of CRBSI, a negative catheter tip culture has a negative predictive 
value of 99%.  
CATHETER RELATED LOCAL INFECTIONS:  
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CRLI is defined as “any sign of local infection (induration, erythema, heat, pain, purulent 
drainage) and catheter tip colonization. This is considered to have a strong predictive 
value for catheter related bloodstream infection. 
 
CATHETER RELATED BLOODSTREAM INFECTION (CRBSI):  
 
Diagnosis of catheter related bloodstream infection comprises of demonstration of 
bloodstream infection as well as evidence that the intravascular catheter is the source of 
infection and there is no other source of infection. This consists of growth of the same 
organism from 1 percutaneous blood culture and from a catheter tip culture or culture 
from the catheter hub and from the peripheral vein meet criteria for quantitative blood 
cultures of differential time to positivity. (12) 
 
1) Differential time to positivity is said to occur when simultaneous blood cultures  
from the peripheral vein and through the central venous catheter are positive. The 
culture via the catheter should become positive 2 hours or more before the 
peripherally drawn culture. This method has a sensitivity of 85% and specificity 
of 91%.(11)  
 
2) Quantitative blood cultures are said to be positive when simultaneous blood 
cultures drawn via the catheter and percutaneously show growth with the catheter 
culture yielding a colony count that is 5 times or more than the peripherally drawn 
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culture. This technique has been shown to have a very high specificity of 99%, 
with a sensitivity of 79%.  
 
 
3) A single quantitative blood culture through the intravascular catheter is drawn 
and processed by pour plate or lysis centrifugation technique. Culture methods 
yielding more than 100 colony forming units is considered to be positive. 
However, this method may also give false positive results in bacteremia, 
especially in immunocompromised patients with sepsis.  
 
4) Qualitative culture from the catheter segment after removal of the device can be 
used to diagnose CRBSI.  
 
In this technique, any growth is considered as evidence of infection. Qualitative 
culture of the catheter segment has been shown to have a specificity of 72% and a 
sensitivity of 90%.(11)  
 
5) Semi-quantitative catheter segment culture: Growth of more than 15 colony 
forming units is considered significant by this method. The sensitivity and 
specificity of this technique are 85% and 82% respectively. The positive 
predictive value is 80% in the setting of high pre-test probability of catheter 
related bloodstream infection. However, in situations with low prevalence, the 
positive predictive value is low.   
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6) Quantitative catheter segment culture that shows the growth of more than 1000 
colony forming units can also aid in diagnosing CRBSI. This test has sensitivity 
and specificity of 83 and 87% respectively.  
 
7) Endoluminal brush sampling: This is a newer diagnostic technique. Endoluminal 
catheter sampling with a special brush permits detection of catheter related 
bloodstream infection without removal of the catheter. This method also has the 
benefit of examining the whole catheter. This is a simple procedure to perform 
and does not have adverse effects.     
 
 
CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTIONS: 
Central Line-Associated Bloodstream Infection (CLABSI) is defined as “a bloodstream 
infection where a central line or umbilical catheter was in place at the time of, or within 
48 hours before, onset of the event.”  
 
LABORATORY CONFIRMED BLOODSTREAM INFECTION:  
Laboratory confirmed bloodstream infections are “infections that are not secondary to a 
community-acquired infection or an HAI meeting CDC criteria at another body site.” 
Laboratory confirmed bloodstream infections should include at least one of the 
following: 
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1. A recognized pathogen has been cultured from 1 or more blood cultures and organism 
cultured from blood is not related to an infection at another site.  
2. Patient has at least 1 of the following signs or symptoms: Fever (temperature >= 38 ° 
C), chills, or hypotension. The patients’ signs and symptoms and positive laboratory 
results should not be related to infection at another site. A common skin contaminant 
must be cultured from 2 or more blood cultures taken on separate occasions. 
This refers to at least 2 blood draws that were collected within 2 days of each other.  
CLABSI definition is used for surveillance and epidemiological purposes. The criteria for 
diagnosis of CLABSI are not stringent. Extensive laboratory evaluation is not necessary 
for a diagnosis of CLABSI. 
Catheter related bloodstream infections constitute 11% of healthcare associated 
infections.(12) They can lead to bacteremia, septic shock, and other complications 
including infective endocarditis, osteomyelitis, spinal epidural abscess, and death. They 
lead to increase in the duration of hospital stay and cost of treatment and contribute to 
morbidity and mortality in these patients. 
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EPIDEMIOLOGY 
 
Hospital acquired or nosocomial infections are defined as “localized or systemic 
condition resulting from an adverse reaction to the presence of an infectious agent(s) or 
its toxin(s). There must be no evidence that the infection was present or incubating at the 
time of admission to the acute care setting.” (16) Nosocomial infections include urinary  
tract infections, ventilator associated pneumonia, bloodstream infections and surgical site 
infections.  
Nosocomial infections can have endogenous or exogenous sources. Endogenous sources 
are body sites including cutaneous sources, mouth, nose and alimentary tract. Exogenous 
sources include healthcare workers, patient visitors and medical devices.  
. It is estimated that 5% of all hospitalized patients eventually develop a nosocomial 
infection. (17) However, the percentage of patients who are affected by hospital acquired 
infections is higher among immunocompromised and elderly patients.  
Catheter associated blood stream infections add to the morbidity and mortality of the 
patients. Studies have shown that catheter related bloodstream infections are associated 
with increase in mortality (Odds Ratio up to  9.5).(18) Patients with catheter related 
bloodstream infections have a longer duration of ICU stay and longer duration of stay in 
the hospital.  Catheter related bloodstream infections also add to the healthcare costs. In 
developing countries, catheter related bloodstream infections contributed to 30% of all 
device associated infections. The mortality rate associated with catheter related 
bloodstream infections was 35.2%. (19)   
. 
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GLOBAL EPIDEMIOLOGY:  
 
The Extended Prevalence of Infection in Intensive Care study was done to assess the 
prevalence of hospital acquired infections. Amongst 13,796 patients included in the 
study, 51% were classified as infected and catheter related bloodstream infections 
comprised 15 % of the above. Medical admission, renal replacement therapy, HIV 
infection, chronic obstructive pulmonary disease and mechanical ventilation were 
associated with greater chance of infection. (20) 
In the Unites States, 2,50,000 catheter related bloodstream infections are estimated to 
occur every year of which 60,000 occur in critically ill patients. Mortality from catheter 
related bloodstream infection is estimated to be approximately 30,000 to 60,000 per year. 
The attributable mortality has been estimated to be up to 25 %. Each episode of catheter 
related bloodstream infection adds approximately 25,000 $ to healthcare costs.  (21) In 
Europe, studies have estimated the rate of catheter related bloodstream infection to range 
from 1.12 to 4.2 per 1000 catheter days.(22)  Bloodstream infections in critically ill 
patients prolong the duration of hospital stay by an average of 12 days. (23) 
Studies have shown that central line related bloodstream infections occur more frequently 
in limited resource countries as compared to developed countries. The rate of central line 
related bloodstream infections ranged from 1.6 up to 44.6 per 1000 catheter days for 
adults in low income countries as compared to countries as compared to 1.5 per 1000 
catheter days in the United States. This has been attributed to low nurse to patient ratio, 
. 
29 
 
inadequate infection control surveillance, lack of adherence to hand hygiene measures 
and limited medical supplies.(24)    
The rate of catheter related bloodstream infections has shown a declining trend over the 
past few years. This is thought to be due to better adherence to aseptic measures, use of 
sterile barrier precautions during line insertion, catheter care and education of healthcare 
staff. In the United States of America, the rate of central line associated bloodstream 
infection has reduced from 43,000 in 2001 to 18,000 in 2009. The rate of central venous 
catheter associated infection has declined from 5 per 1000 catheter days to 2.05 per 1000 
catheter days over a period of 10 years from 1998 to 2009 in the United States of 
America. (25) Other studies have demonstrated reduction of 70% in CRBSI rate. (26) 
Nevertheless CRBSI still result in significant morbidity and mortality.  
 
EPIDEMIOLOGY - INDIA 
The incidence of hospital acquired infections in a tertiary care hospital in India was found 
to be 17.6%. This observational study included 293 consecutive patients admitted to the 
Surgical Intensive Care Unit in 2009 - 2010. Amongst 37 patients who developed 
nosocomial infections, 50% had ventilator associated pneumonia, 27.7% had catheter 
related bloodstream infection and 22.2% of patients were found to have catheter 
associated UTI. There were 10 catheter related bloodstream infections during the study 
period, with a rate of 16 per 1000 catheter days. The chance of developing nosocomial 
infections significantly increased with the duration of stay in Intensive Care Unit. (27) 
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In a study published by Chopdekar et al, over a 1 year period in 2008 – 2009, the 
bloodstream infection rate in critically ill adult patients due to central venous catheters 
was found to be 7.57 per 1000 catheter days. The rate in the neonatal and pediatric 
intensive care units in the same study was found to be 27.02 and 8.64 per 1000 catheter 
days respectively. Patients with catheter related bloodstream infection had mortality rate 
of 33% as compared to a rate of 20% in patients with bloodstream infection not related to 
central venous catheters.  (28)  In another study from India, rate of central line related 
bloodstream infections was 8.75 per 1000 catheter days. (29)  
Our hospital has a nosocomial infection surveillance program as a part of which all 
patients in Intensive Care Units (ICU) are monitored. The catheter related bloodstream 
infection rate in the year 2012-2013 among patients in Medical Intensive Care Unit and 
High Dependency Unit  was 2.4 per 1000 catheter days and 2.5 per 1000 catheter days 
respectively. (unpublished data) 
 
EXPENDITURE:   
The total attributable cost of catheter associated bloodstream infection was found to vary 
from 11,971$ to 13,585$ per episode in studies in the United States. (23,30).  
In Europe, estimated additional costs due to CRBSI was 4200 to 11,380 euros per episode 
among different nations.(22) 
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 In a prospective observational study conducted over a 6 month period in Christian 
Medical College Vellore in 2012, the direct expenses (including hospital bill and cost of 
medications) associated with one CRBSI in critically ill patients was found to be 2.3 lac 
rupees. The average extra duration of hospital stay in patients with CRBSI was 9 days. 
(unpublished data)  
 
PATHOGENESIS 
 
Contamination of central venous catheters can occur via several routes.  
1) Extraluminal : 
Skin flora from the central venous catheter insertion site move along the exterior surface 
of the catheter. They proceed through the subcutaneous tract of the catheter ultimately 
reaching and colonizing the catheter tip. 
 
2) Intraluminal :  
Contamination of the catheter hub by healthcare workers hands, contaminated fluids or 
devices leads to colonization of the intraluminal surafceof the catheter.  
 
3) Hematogenous spread : 
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 Bacteremia due to infection at another site can lead to hematogenous seeding and 
colonization of the catheter tip.  
 
4) Contaminated infusate:   
Acquiring infection due to contaminated infusate occurs rarely and leads to epidemics of 
catheter related bloodstream infection.  
 
Other factors that play a role in the pathogenesis of catheter related bloodstream infection 
include the following: 
 
1) Material of the device:  
 
In a study by Hawser et al, biofilm formation by Candida species was found to be more 
with latex and silicone elastomer catheters as compared to polyurethrane and 100 % 
silicone catheters. (31) Irregularities of the surface of the central venous catheter also 
promotes development of colonization and infection. However, another study which 
included polyurethrane, polyvinyl chloride, and polytetrafluoroethylene central venous 
catheters did not find any difference in colonization rate between different catheter 
materials.  
 
. 
33 
 
2) Virulence of the organism :  
 
Candida albicans has a more rapid biofilm formation is more pathogenic that Candida 
parapsilosis, Canida glabrata and Candida pseudotropicalis.(31) Staphylococcus aureus 
and Staphylococcus epidermidis produce clumping factors A and B and thrombospondin 
which facilitate adherence to the catheter surface. (32–34)  
In a study conducted in the United States from 1998 to 2000, which included 1263 
catheters with 35 bloodstream infections, 45% of the infections were extraluminally 
acquired and 26% were intraluminally acquired. (35) 
 
BIOFILM FORMATION 
 
In adverse environmental conditions, bacteria form biofilms. Biofilms are a matrix of 
extracellular polymeric substances produced by the bacteria along with an acellular or 
abiotic component.  Biofilms confer resistance to antimicrobials by providing a diffusion 
barrier to antibiotics. The microorganisms have a slower growth rate and slow rate of 
antibiotic uptake.  
Bacterial cells that grow in biofilms exist in adverse environmental conditions with 
unfavourable pH, nutrient and oxygen deficient conditions. They may undergo 
transformation into forms that have an altered, slower metabolic state. (36) 
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Biofilms have an important role to play in the pathogenesis of infective endocarditis, 
chronic prostatitis, cystic fibrosis. They are also important in device related infections 
including catheter related bloodstream infection, catheter related urinary tract infection, 
contact lens infection, and prosthetic valve endocarditis.  Mechanisms by which biofilms 
confer antimicrobial resistance include production of endotoxins and providing a niche 
for development of resistant bacteria. Detachment of bacteria from the biofilms can lead 
to bacteremia and catheter related urinary tract infections.(37)  
Biofilms of central venous catheters can be present along the external or internal surface 
of the device.  Migration of skin flora leads to biofilm formation on the outer surface 
whereas contamination from hands of healthcare workers at the catheter hub leads to 
biofilm formation on the inner surface. As central venous catheters are invariably in 
contact with blood, there is coating of the outer surface with plasma proteins including 
albumin, fibronectin, fibrinogen and laminin. This promotes adherence of bacteria 
especially Staphylococcus aureus and Staphylococcus epidermidis. (38)   Central venous 
catheters with a fibrin sheath are more likely to be colonized that those without. (39)  
Studies have shown that colonization happens within hours of central venous catheter 
insertion. The presence of a thrombus increases the risk of infectious complications.  
For short term CVCS, organisms that are part of the cutaneous flora have been implicated 
in causing CRBSI. For long term CVCs, colonization of the catheter lumen is the 
predominant mechanism.   
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The possibility of a catheter related blood stream infection should be suspected when the 
patient with an indwelling central venous catheter becomes febrile, the presence of 
warmth, tenderness, redness or pus at the CVC site.  
 
MICROBIOLOGY   
 
The normal skin flora consists of resident and transient bacteria.  
The resident bacteria exist in the deeper layers of the skin, and are also known as 
colonizing bacteria. These are not removed during hand washing.  
Transient or contaminating bacteria occur superficially and are removed by washing with 
soap and water. Both colonizing and non-colonizing bacteria are involved in the 
pathogenesis. 
Central line related blood stream infections can be caused by Gram positive bacteria, 
Gram negative bacteria and fungi. Gram positive cocci account for the majority of 
intravascular catheter related bloodstream infections worldwide. Amongst Gram positive 
cocci, Coagulase negative Staphylococcus is the most common organism causing catheter 
related infection.  
 
WORLD:  
According to the SCOPE study, coagulase negative Staphylococcus accounted for 31% of 
bloodstream infections, whereas Staphylococcus aureus and Enterococcus account for 
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20% and 9% of infections respectively. Gram negative organisms causing central line 
related bloodstream infection include Escherichia coli, Klebsiella, Acinetobacter, 
Pseudomonas aeruginosa and Serratia. Gram negative organisms accounted for 22% of 
intravascular device related infections. Candida species were found to cause 9% of 
catheter related bloodstream infections. (40) 
This is in contrast to the pattern that was observed in the 1970s and 1980s in developed 
countries. Gram negative organisms caused the majority of catheter related bloodstream 
infections during those days, the commonest bacteria being Escherichia coli. (41) 
 
INDIA: 
The profile of micro-organisms causing catheter related bloodstream infections in India is 
diverse. Gram negative bacteria have been implicated in a significant proportion of 
central venous catheter related infections.  The proportion of catheter related bloodstream 
infections due to Gram negative bacilli is higher in India compared to Western estimates. 
(42)A study conducted in a tertiary care cardiac centre in India over a 6 month period in 
2001 found 35 catheter related bloodstream infections in 1314 patients admitted for 
cardiac surgery. 47% of infections were caused by Escherichia coli, 11.7 % by 
Acinetobacter, 5.8 % by Enterobacter, and 5.8% by Proteus species.(43).  However, 
several other studies have found coagulase negative Staphylococci to be the most 
common organism implicated in catheter related bloodstream infection. (18,19,33).     
The majority (87%) of catheter related bloodstream infections are monomicrobial. 
Coagulase negative Staphylococci, Acinetobacter, Serratia, Candida and Enterobacter 
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were more likely to cause infection among ICU patients. Catheter related bloodstream 
infection in the ward was usually caused by Staphylococcus aureus, Klebsiella, and 
Escherichia coli.  Fungal infections were caused most commonly by Candida albicans 
(54%), followed by Candida tropicalis, Candida parapsilosis and Candida glabrata. The 
mortality rate was found to be higher for Candida and Pseudomonas bloodstream 
infections as compared to Escherichia coli and coagulase negative Staphylococci . (40) 
 
FACTORS THAT INFLUENCE THE DEVELOPMENT OF INFECTIOUS 
COMPLICATIONS 
1) Number of lumens: 
  
Central venous catheters can have up to 5 lumens. The use of multi-lumen 
catheters offers the advantage of simultaneous administration of several drugs, 
intravenous fluids or inotropes. However, multi-lumen central venous catheters 
have a higher chance of colonization and catheter related bloodstream infection. 
Increased manipulation in case of multi-lumen catheters have also been thought to 
be associated with a higher risks of catheter related bloodstream infection. Triple 
lumen catheters are the preferred catheters that are inserted in critically ill patients 
requiring a central venous access. A meta-analysis by Dezfulian et al looking at 
the rates of infectious complications between single and multi-lumen catheters 
found a higher incidence of catheter related bloodstream infection with multi-
lumen catheters with an odds ratio of 2.15. However, they did not find any 
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significant difference between the 2 groups with respect to catheter colonization. 
(44) 
 
2)  Ultrasound :  
 
Ultrasound guided central venous catheter insertion has been found to have a 
lower rate of mechanical complications, number of attempts at insertion, reduced 
time for central venous catheter insertion . However, whether this translates into a 
lower chance of development of infectious complications is not clear. Further 
studies need to be conducted in this field to draw clinical implications.  
 
3) Duration:  
 
The chance of development of infectious complications is higher as the duration 
of CVC increases. In a case control study conducted in a tertiary care centre in 
India the duration of catheter was found to be a predisposing factor for the 
development of CRBSI. 
 The mean duration was found to be higher among the cases (14.06 days) than 
controls (10.96 days). (21) 
Duration of catheterization more than 1 week was associated with increased 
colonization of the central venous catheter tip. (45) This led to the concept of 
periodic replacement of central venous catheters in critically ill patients. 
However, routine replacement of central venous catheters has not been shown to 
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be useful. Replacement of central venous catheters at scheduled time intervals is 
not recommended. 
 Routine replacement of central venous catheters, pulmonary catheters and arterial 
line was studied by Eyer et al in 112 patients. Patients were randomized to 3 arms: 
I – Weekly change to a new site, II – Change only when clinically indicated to a 
new site, III – Weekly change to same site by catheter exchange. They did not 
find a difference in the rate of catheter tip colonization or central line related 
bloodstream infection between weekly change of CVC compared with patients 
whose catheters were replaced as indicated. (46)   
It is prudent to keep central venous catheters in situ as long as they are indicated 
and they should be promptly removed when unnecessary.  The available evidence 
does not support routine CVC changes unless clinically indicated. Though there is 
a definite risk of catheter related bloodstream infection with increase in the 
duration of the central venous catheter, one must consider the risk of mechanical 
complications involved with the change of central venous catheter when clinically 
not indicated 
 
4) Guidewire exchange strategies:  
 
A meta-analysis by Cook et al was conducted to evaluate the effect of scheduled 
catheter changes on the rate of catheter colonization and infection. 
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 Change of central venous catheters with the help of guide wires was associated 
with a trend toward a higher frequency of catheter colonization with relative risk 
of  1.26.  
The rate of catheter exit site infection was higher in the guide wire exchange 
group. The frequency of central venous catheter related bacteremia also showed a 
rising trend in the guide wire exchange group though the difference was not 
statistically significant. (relative risk 1.72, 95% confidence interval 0.89 to 
3.33).(47) Guide wire exchange as a strategy to reduce the rate of central venous 
catheter related complications is currently not recommended. (48) 
. 
5) Maximal sterile precautions: 
 
Use of maximal sterile barrier precautions is recommended during central venous 
catheter insertion. This includes wearing a cap, mask, sterile gloves and gown and 
a sterile drape. Raad et al compared standard sterile precautions consisting of 
sterile gloves and small drape to maximal sterile precautions consisting of mask, 
cap, sterile gloves, sterile gown and large drapes. A randomized controlled trial 
was performed in a 500 bedded tertiary care center which recruited 343 patients.  
The controls had 6 times the incidence of catheter related infectious complications 
compared to the maximal barrier group. Cost benefit analysis proved high cost 
effectiveness of this precaution. (49) 
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Another prospective study by Lee et al included 133 seriously ill patients who 
received a central venous catheter insertion in the emergency department or 
intensive care unit in a hospital in Seoul, Korea over an 8 month period in 2006. 
Out of 42 patients for whom maximal sterile barrier precautions were used, only 1 
patient (2.4%) developed a catheter related bloodstream infection. Among 91 
patients without the benefit of such precautions,14 patients (15.4%) developed 
catheter related bloodstream infection. This difference was statistically significant 
with odds ratio of 5.205 (Confidence Interval 0.015–1.136) and p value of 0.023. 
This study also found that the use of a mask led to decreased rate of bloodstream 
infection secondary to CVC with an odds ratio of 4.707 (confidence interval 
0.020–0.819) and p value of 0.030.  
In a landmark initiative implemented by Pornovost et al, simple checklist guided 
management of central lines including the maximal sterile barrier precautions 
showed significant reduction in the central line related sepsis. The rate of central 
line related bloodstream infections was 2.7 per 1000 catheter days at baseline to 
0.62 per 1000 catheter days at 3 months ( p value 0.001, confidence interval 0.47–
0.81)  (50) 
 
6) Skin preparation:  
 
Skin preparation with chlorhexidine solution of more than 0.5% concentration 
along with alcohol is recommend during insertion and dressing changes of central 
venous catheter. Though povidone iodine was traditionally used for skin 
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preparation, there is adequate evidence to support the use of chlorhexidine for 
skin preparation prior to central venous catheter insertion.  
A prospective study by Maki et al was conducted to assess the efficacy of 
cutaneous antisepsis to prevent central venous catheter associated infections. They 
studied three antiseptics for disinfection of patients' catheter insertion sites - 10% 
povidone-iodine, 70% alcohol, or 2% aqueous chlorhexidine disinfection of the 
site before insertion and for site care every alternate day. The patients who were 
in the chlorhexidine arm had the lowest incidence of local catheter-related 
infection (2.3 per 100 catheters vs 7.1 and 9.3 for alcohol and povidone-iodine, 
respectively, p = 0.02). The incidence of catheter related bacteraemia was also 
lower in the chlorhexidine arm as compared to the other 2 arms with an odds ratio 
of 0.16 and p value of 0.04.  
A trial published by Mimoz et al compared 10 % povidone iodine to a 
combination of chlorhexidine, benzalkonium and benzyl alcohol. This study 
included both central venous as well as arterial lines. The colonization rates in the 
chlorhexidine group and iodine group were 8 and 31 per 1000 catheter days 
respectively with a relative risk of 0.3, 945% confidence interval  0.1 to 1 and p 
value of 0.03.   The sepsis rates were 5 and 19 per 1000 catheter days respectively 
with relative risk of 0.3, 95% confidence interval of 0.1 to 1 and p value of 0.02. 
Subgroup analysis revealed that Gram positive bacterial infections were prevented 
with a higher efficacy with chlorhexidine in this study.  
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Dressings to cover the site of insertion of a central venous catheter include sterile 
gauze or transparent semipermeable dressings. However, gauze dressings are 
preferred if there is bleeding, oozing or if the patient is diaphoretic.   
 
7) Obesity: 
 
          Though the association of obesity with catheter related infectious complications is 
not proven, obesity has been shown to influence the integrity of the catheter 
dressings and the colonization rate of central venous catheters. In a study done 
among internal medicine ward patients with central venous catheters, inadequate 
dressings were more likely among patients who were obese, adjusted odds ratio, 
3.4 (51)  
           In a randomized controlled trial looking at the rates of infectious complications in 
hemodialysis catheters, patients with a higher BMI had  higher incidence of 
colonization in the femoral group as compared to the jugular group – 50.9 versus 
24.5 per 1000 catheter days respectively. Jugular catheterization was associated 
with increased incidence of catheter colonization as compared to  femoral 
catheterization (45.4 vs 23.7 per 1000 catheter-days; HR, 2.10; 95% CI, 1.13-
3.91; P=.017) in the patients with low BMI (24.2). However, there was no 
difference in catheter related bloodstream infection in patients with high and low 
BMI.  
 
8) Antibiotic coated catheters:   
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Catheters coated with minocycline and rifampicin, chlorhexidine and sulfadiazine and 
silver impregnated catheters have been used in order to reduce catheter related 
infectious complications. Multiple studies have been done to assess the benefits of 
antibiotic coated catheters. A meta-analysis conducted by Hockenhull et all which 
included 38 randomized controlled trials found that central line related bloodstream 
infections were lower in the patients with antibiotic coated catheters (odds ratio 0.49 ; 
95% confidence interval 0.37-0.64) (52). In a subgroup analysis the benefit was 
pronounced in the second generation central venous catheters. (Odds Ratio - 0.26, 
95% confidence interval - 0.15-0.46). However, most of the studies had 
methodological flaws. There was wide heterogeneity in the studies and almost all 
studies were funded by the catheter manufacturing companies. Another systematic 
review by Neil-Weise et al  consisted of 21 trials of which 18 trials showed benefit. 
The number needed to treat ranged from 12 to 182 and almost all the studies had 
methodological flaws. (53)  
The risk of development of antibiotic resistance is a cause for concern when antibiotic 
coated catheters are used. The application of topical ointment or creams at insertion 
sites of central venous catheters is not recommended as it can promote bacterial 
resistance and fungal infection. (54,55) 
 
9) Dressings: 
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Various dressings are used to cover the insertion site of the central venous catheter over 
the skin. Gauze dressing is used traditionally and there are newer transparent 
polyurethane dressings like Tegaderm and Opsite. At present there is no clear benefit of 
either material. Polyurethane dressings bear the advantage of ease of application and 
earlier recognition of skin erythema and infection at the puncture site. A Cochrane review 
published in 2003 compared gauze and polyurethrane dressings. They did not find any 
significant difference in the rate of CRBSI between the 2 groups. (56) Another Cochrane 
systematic review published in 2011 found that catheter related bloodstream infections 
were more in the polyurethane group when compared with gauze dressings with an odds 
ratio of 4, 95% confidence interval ranging from 1.02 to 17.23. However, these 
comparisons were made with studies which had small sample sizes. (57) 
SITE OF INSERTION 
 
The site of insertion of the central venous catheter is thought to influence the rate of 
infectious complications. It is believed that femoral central venous catheters carry a 
greater risk of infectious complications compared to internal jugular and subclavian 
catheters. The femoral insertion site is in proximity to the perineal region which is 
colonized by the genitourinary flora. Femoral central venous catheters are preferred in an 
emergency. In such circumstances, adherence to aseptic precautions may not be strictly 
followed.   
Earlier studies had shown a higher rate of infectious complications with femoral central 
venous catheters. In a study conducted in critical care units in France over a three year 
period from 1997 to 2000, mechanical, infectious and thrombotic complications of 
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subclavian and femoral central venous catheters were assessed. Among the 270 catheters 
assessed for infectious complications, the incidence of infectious complications was 20 
per 1000 in the femoral arm and 3.7 per 1000 in the subclavian arm. 4.4% of the femoral 
catheters had infectious complications as compared to 1.5% of the subclavian 
catheters.(5) A prospective observational study  conducted in 2005 found a higher rate of 
colonization and catheter related bloodstream infection in femoral group as compared to 
the internal jugular and subclavian group.  
However, over the last few years, the overall rate of infectious complications associated 
with central venous catheters has decreased. This is thought to be due to strict adherence 
to aseptic precautions during central venous catheter insertion, better catheter care and 
education and training of healthcare personnel.  
A randomized controlled trial in France conducted from 2004 to 2007 found that the rate 
of colonization in hemodialysis catheters in the jugular and femoral group were 40.8 and 
35.7 per 1000 catheter days with no statistically significant  difference between the two 
groups.  
The rate of catheter related bloodstream infection in the jugular and femoral groups were 
2.3 per 1000 catheter days and 1.5 per 1000 catheter days respectively. The difference 
between the two groups was not statistically significant.  (58) 
 A systematic review and meta-analysis to determine the risk of catheter related 
infectious complications due to CVCs at femoral region compared to neck CVCs was 
published by Maki et al in 2012.  This review included randomized controlled trials as 
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well as cohort and observational studies  that compared the rate of catheter related 
bloodstream infection at the subclavian or internal jugular and femoral site. The 
frequency of venous thrombosis at different sites, along with the prevalence of CRBSI  
was recorded. The rate of CRBSI was 2.5±1.9 per 1000 central venous catheter days with 
a range of 0.6 to 7.2. There was no significant difference between the subclavian / 
internal jugular group and the femoral group in the risk of catheter related bloodstream 
infections in the randomized controlled trials. Other trials showed a significant risk with 
femoral site when compared to the internal jugular site with relative risk of 1.90 and 
confidence interval of 1.21 – 2.97. However this apparent difference could be explained 
by 2 studies which were statistical outliers. When those two studies were discounted, 
there was no significant difference (relative risk 1.35 (95% CI 0.84 – 2.19).  Meta 
regression analysis was also done which showed that studies published earlier favoured 
the subclavian and internal jugular site of insertion of central venous catheters.  There 
was no significant difference in the rate of catheter related bloodstream infection between 
the femoral and the internal jugular sites with a relative risk of 1.35 and confidence 
interval of 0.84 to 2.19. The risk of development of deep vein thrombosis was recorded in 
two studies. There was no significant difference in the rates of deep vein thrombosis 
between the different sites of central venous catheter insertion. However, there was 
heterogeneity between studies. (59)   
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JUSTIFICATION FOR THE STUDY 
 
 
Though earlier studies favoured the subclavian and internal jugular route of central 
venous catheter insertion as compared to the femoral route for prevention of infectious 
complications, recent studies have failed to show similar results.  
The site of central venous catheter insertion should be chosen depending upon the skill of 
the operator as well as the risk of mechanical and infectious complications. The femoral 
site of central venous catheter insertion is often avoided as it is thought to be associated 
with a higher risk of infectious complications and deep venous thrombosis.  However, the 
risk of life threatening mechanical complications, specifically pneumothorax and 
hemothorax is present only with the insertion of subclavian and internal jugular central 
venous catheters. In the event of puncture or cannulation of the adjacent artery, it is easier 
to apply compression to the femoral artery rather than the internal carotid or subclavian 
artery. Catheterization of the femoral vein requires less skill and can be done with ease by 
relatively inexperienced operators.  
Over the years the overall rate of central venous catheter related bloodstream infections 
has shown a significant decline. Marik’s study (59) demonstrated a relation between the 
rate of infections and the time of publication. The femoral CVCs had an increased CRBSI 
rate in the earlier studies whereas recent studies have shown little difference. There is 
limited data in this field in the Indian scenario.  
Therefore we decided to do this study to conclude if one site is better than the other.  
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METHODOLOGY 
 
STUDY DESIGN: Randomized controlled trial 
STUDY POPULATION: Patients more than 15 years of age admitted in Medical 
Intensive Care Unit and Medical High Dependency Unit who required the insertion of a 
central venous catheter were included in the study 
STUDY SETTING: Christian Medical College Vellore is a teaching tertiary care 
hospital situated in Tamil Nadu 140 Km west of Chennai. It was established in 1900 and  
forms one of the important referral centers in South India.  There are about 2700 bed 
overall with 168 beds dedicated for ICU care. Medical Intensive Care Unit (ICU) and 
Medical High Dependency Unit (HDU) have 12 beds each with a total of 24 beds which 
function as an open system with the General Medicine units admitting patients directly. 
Medical Intensive Care Unit admits patients from all specialties whereas Medical High 
Dependency Unit beds are restricted to the General Medical units only.  
The average number of admissions is 67.1 per month in the MICU and 58.1 in MHDU. 
The number of central line days in MICU and MHDU are 252.4 and 240.4 days 
respectively.  
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INTERVENTION: There were 2 arms 
i) Internal jugular  central venous catheter 
ii) Femoral central venous catheter 
Patients were allocated to the 2 arms with a 1:1 ratio 
 
PRIMARY OUTCOME 
 
 
The rate of colonization in internal jugular central venous catheters and femoral central 
venous catheters inserted in Medical Intensive Care Unit  and Medical High Dependency 
Unit.  
 
 SECONDARY OUTCOME 
 
The rate of catheter related bloodstream infection in internal jugular central venous 
catheters and femoral central venous catheters inserted in Medical Intensive Care Unit 
and Medical High Dependency Unit.  
 
CATHETER TIP COLONIZATION 
. 
51 
 
This is defined as growth of more than 15 colony-forming units of a micro-organism 
from the central venous catheter tip using semi-quantitative culture methods (Maki’s roll 
plate technique). 
 
CATHETER RELATED BLOODSTREAM INFECTION (CRBSI) 
This is defined as positive semi- quantitative (>15 CFU) cultures from the catheter tip 
and positive peripheral blood cultures where the same micro-organism with the same 
species and antibiogram is isolated from the catheter segment and peripheral blood. 
 
STUDY PERIOD: This study was conducted over a 1 year period from July 2013 to 
June 2014  
 
METHOD OF RANDOMIZATION: Computer generated block randomization with 
varying block size was used. There were 2 sets of random numbers. These were used for 
Medical Intensive Care Unit and Medical High Dependency Unit respectively.  
 
ALLOCATION CONCEALMENT: Opaque sealed envelopes were used to ensure 
allocation concealment. 
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BLINDING: This was a single blinded randomized controlled trial. The microbiologists 
who interpreted the central venous catheter tip culture results were not aware of the site 
of the central venous catheter. The patient and physician were aware of the site of the 
central venous catheter.  
TYPE OF TRIAL: Non inferiority trial 
 
SAMPLE SIZE CALCULATION 
 
This was based on an earlier study which compared the colonization rate between central 
venous catheters at different insertion sites. (8) 
 
FORMULA FOR SAMPLE SIZE 
   
      
 
      
 
  
 
 
where, 
   
 
   is   5% level of significance = 1.96 
      is the power of the study = 0.842 
d = 14% clinically important difference between the 2 groups 
P = average percentage in the two groups  
Q = 100 – P  
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  = 
 
      
 
Where, r = 5% exclusion for whom catheter tip is not sent for culture 
  
 
 With 80% power and 5% level of significance, with a clinically important difference of 
14 % between the 2 groups, and 5% exclusion for whom the catheter tip is not sent for 
culture, the required sample size was 89 in each arm.  
  
INCLUSION CRITERIA  
 
Patients more than 15 years of age admitted in Medical Intensive Care Unit and Medical 
High Dependency Unit who require insertion of a central venous catheter. 
 
EXCLUSION CRITERIA  
 
• Deep vein thrombosis (upper or lower limb) 
• Cardiac arrest in the last 24 hours 
• Pregnant women 
• Immunocompromised patients (HIV infection, malignancy, patients on 
immunosuppressant, chemotherapy and post renal transplant patients) 
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• Coagulopathy (Coagulopathy was defined as INR of 2 or more or 
thrombocytopenia with platelet count less than 50,000/ml) 
• Skin lesion (femoral or neck region) 
• Profound volume overload that precludes putting the patient in Trendelenbergs 
position  
• Insertion of a central venous catheter in the last 7 days  
• Patients or relatives of patients who do not give consent  
• Operator preference – If the physician who is performing the central venous 
catheter insertion is not confident of insertion of a central venous catheter in 
either the internal jugular or the femoral site for that patient  
 
ANALYSIS: Per protocol analysis  
 
REMOVAL OF CENTRAL VENOUS CATHETER 
 
The central venous catheter was removed when deemed necessary by the treating physician.  
 
Reasons for removal included the following: 
1) Central venous catheter was no longer required 
2) Suspected central venous catheter related bloodstream infection 
3) Catheter related deep vein thrombosis 
4) The patient had expired  
5) Misplaced central venous catheter 
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The central venous catheter tips of all the patients included in the study were sent for culture. 
 
DESCRIPTION OF THE STUDY 
 
This study was conducted with the purpose of assessing the rate of infectious 
complications of internal jugular and femoral central venous catheter. This was a 
randomized controlled trial in which the site of central venous catheter insertion was 
determined by randomization. Patients admitted to the Medical Intensive Care Unit and 
Medical High Dependency Unit who required the insertion of a central venous catheter 
were assessed for eligibility for inclusion into this study. Patients were recruited from 
July 2013 to June 2014. The treating physician assessed the patients for eligibility into 
the study. The details of the study were explained to the patient and/or relatives in their 
regional language. Those who were willing to participate in the study and gave written 
consent were recruited into the study. Opaque sealed envelopes were used. After a patient 
was decided to be included in the study, the physician would open the envelope where the 
site is mentioned.   
The central venous catheters were inserted by registrars and interns (under the 
supervision of the registrars). The registrar had the option of inserting the catheter under 
ultrasound guidance or blindly with the help of anatomical landmarks. The ultrasound 
machine used was SonoSite MicroMaxx P 17/5-1 MHz, manufactured by SonoSite, Inc. 
Bothell, Washington, United States of America. 
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There were 2 arms with equal allocation: 
i) The first arm included patients with internal jugular central venous catheter. 
ii) The second arm included patients with femoral central venous catheter.   
 
Informed consent was obtained from the patients or the relatives of the patient (Informed consent 
form - Appendix I). The colonization and catheter related bloodstream infection rates in the 
patients included in the study were calculated.   
Patients for whom the central venous catheter was being changed were excluded from the study. 
This is because infectious complications in these patients could be due to the new or the old 
central venous catheters.  
If central venous catheter insertion at the specified site was unsuccessful after multiple attempts, 
then a different site would be chosen for insertion and the patient would be excluded from the 
study. Central venous catheters were inserted under aseptic precautions. The operator performing 
the catheter insertion wore sterile gown, mask, cap and gloves. The insertion site was cleaned 
with 2% chlorhexidine gluconate solution. In case of internal jugular vein catheters, the 
placement of the catheter was confirmed by chest X ray prior to administration of medication or 
intravenous fluids. 
   
The central venous catheters used in this study were triple lumen catheters (Arrow Multi-
lumen Central venous Catheterization Set with Blue FlexTip catheter  REF CV – 12703) 
with a single 16 gauge lumen and two 18 gauge lumens. These catheters are made of 
polyurethrane. They are 7 French catheters which are 16 cm in length.  They are radio 
opaque and are non-medicated catheters. Transparent film dressing were used which were 
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changed every 3 days. In case of excessive secretions or oozing from the site, gauze 
dressings were used.  
The central venous catheters were removed under aseptic precautions by the registrar or 
intern. The distal 5 cm of the catheter along with the tip was excised and sent for culture.   
Semi-quantitative culture method was used Maki’s roll plate technique. The catheter tip 
was rolled on agar culture plate and incubated at 37 degrees Celsius. The culture plate 
was examined at 24 and 48 hours to look for colony forming units. Colony morphology, 
gram staining and biochemical identification of the organism was done by the routine 
laboratory methods. At the time of recruitment of patients into the study, preliminary data 
was recorded. This included patient related factors (i.e. age, sex, comorbidities, current 
problems, diagnosis, indication for central venous catheter insertion) and procedure 
related factors (i.e number of attempts at catheter insertion, ultrasound guidance, registrar 
or intern and operator experience).  
The patient was followed up for any symptoms and signs of central venous catheter 
related infection.  Presence of new onset fever spikes, bacteremia as detected by blood 
culture, signs suggestive of Catheter Related Local Infection including pain, redness, 
purulent discharge at the site of CVC insertion were recorded.  
The central venous catheter tip was sent for culture for all patients.  For patients in whom 
CRBSI was suspected, the catheter tip was sent for culture as part of routine 
investigations. In patients for whom CRBSI was not suspected, the catheter tip was also 
sent for culture on removal of the catheter. This was funded by the study.  
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The microbiologist interpreted the reports of the central venous catheter tip culture. 
Growth of more than 15 Colony Forming Units on culture of the central venous catheter 
tip was considered as colonization.  
For patients with fever who were suspected to have a central line related bloodstream 
infection, peripheral blood cultures were also sent.  
All blood cultures were drawn using chlorhexidine skin preparation. 6-10 ml of blood 
was sent in BacT/Alert 3D blood culture media. This consists of 40 ml of tryptic soy 
broth (TSB.) It is processed via BacT/Alert systems (bioMérieux, Hazelwood, Missouri, 
USA) with colorimetric sensor technology that allows complete automated detection of 
any growth. Growth is detected as early as 6 hours following incubation. In case of any 
positive result, it is incubated on blood agar and MacConkey agar. Further identification 
is made based on the colony morphology and biochemical methods based on the growth 
obtained. In case of no growth, the culture medium is left in the automated systems for 5-
7 days before labeling as a negative culture. 
 
DATA COLLECTION 
 
 
Data was collected onto a predesigned clinical research form (Appendix II). At the time of central 
venous catheter insertion, the following were planned for collection: 
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PATIENT RELATED FACTORS: 
 
1. Age and sex 
2. Indication for central venous catheter insertion 
3. Comorbidities (diabetes mellitus, hypertension, chronic kidney disease, chronic 
obstructive pulmonary disease) 
4. Site of insertion of central venous catheter 
5. Number of days of hospital stay prior to insertion of central venous catheter 
6. Admission diagnosis 
7. Vitals signs at admission 
8. APACHE II score (Appendix III) 
9. Side and site of central venous catheter insertion 
 
OPERATOR / PROCEDURE RELATED FACTORS:  
 
1. Number of attempts at catheter insertion 
2. Whether the catheter was inserted under ultrasound guidance 
3. Time at which central venous catheter insertion was done 
4. Place of central venous catheter insertion  
5. Experience of the operator performing the central venous catheter insertions 
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At the time of central venous catheter removal, the following data were planned for 
collection: 
1. Final diagnosis of the patient 
2. Number of central venous catheter days 
3. Reason for removal of the central venous catheter 
4. Immediate complications of central venous catheter insertion 
5. Local examination – presence of purulence, warmth, tenderness at the catheter 
insertion site  
6. Did the patient have fever, chills , hypotension from central venous catheter insertion 
till removal 
7. Arterial line – site, number of days of arterial line 
8. Whether the patient required mechanical ventilation 
9. Whether the patient had a tracheostomy 
10. Whether the patient required inotropic support  
 
FUNDING  
 
A FLUID Research grant (Institutional Grant) was approved for the purpose of the study. The 
fund was used for the culture of the central venous catheter tips.  
 
INSTITUTIONAL REVIEW BOARD APPROVAL AND ETHICAL 
CONSIDERATIONS 
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Institutional Review Board (Research and Ethics Committee) approval was obtained prior to the 
commencement of the study (IRB minutes number 8134 dated 19.12.2012- appendix VI). Written 
consent was obtained prior to insertion of central venous catheter for all patients. Permission was 
obtained from the parent units prior to including their patients in this study.  
 
 
STATISTICAL ANALYSIS 
 
Data from the Clinical Research Form was entered into Microsoft Excel spreadsheet. The 
distribution of continuous variables like age was expressed in terms of mean and standard 
deviation. All categorical variables were expressed using frequencies and percentages. 
Chi-square test exact was used to find the difference between the colonization rates 
across the 2 groups. The results were analyzed using SPSS version 17. Per protocol 
analysis was done.   
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RESULTS  
 
 
Flowchart of patients included in the study: 
 
One hundred and fourteen patients were included in the study. Fifty seven patients were 
recruited in the femoral and internal jugular arm each. Informed consent was obtained from 
all patient / patients relatives for participation in the study. In the patients in the jugular arm, 
forty four tips were sent for culture. For 13 patients, the central venous catheter tips were not 
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sent for culture. The femoral arm had 57 patients, of whom central venous catheter tips were 
sent for culture in 46 patients. 90 patients were included in the final analysis.  
The reason for tips not being sent for culture were that the central venous catheter was 
discarded after removal, the patient was discharged at request with the central venous catheter 
in situ or the patient was transferred to another healthcare facility with the central venous 
catheter.   
 
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS: 
 
AGE DISTRIBUTION 
The mean age of patients in the jugular group and femoral groups were similar (45.84 versus 
45.84 years) respectively. 
  
Fig. 1: Age distribution of patients in the jugular and femoral group. 
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The majority of patients across both arms belonged to 51 to 70 year age group (Figure 1). In the 
internal jugular group, 45% of the patients were between 51 – 70 years. 38.6% of the patients 
were between 15 – 30 years of age in the internal jugular group. In patients with femoral 
catheters, 34% belonged to the 51 – 70 year age group and 30% in the 15 – 30 year age group. 
13% of patients in the femoral group were above 70 years as compared to 6.8% in the jugular 
group.   
 
SEX DISTRIBUTION 
 
In this study, 64.4 % of patients were males and 35.6% were females (Figure 2). Sex ratio (1.77 : 
1)  was in favour of males. 61.3% of patients in the internal jugular group were males whereas 
67.4% in the femoral group were males.  
 
 
Fig. 2: Sex Distribution in the internal jugular and femoral groups 
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STATE WISE DISTRIBUTION OF PATIENTS 
 
 
Table 1: State wise distribution of patients  
STATE NUMBER OF PATIENTS PERCENTAGE 
Andhra Pradesh 14 15.6% 
Jharkhand 1 1.1% 
Karnataka 1 1.1% 
Kerala  1 1.1% 
Tamil Nadu 67 74.5% 
West Bengal 6 6.6% 
 
Most of the patients were from Tamil Nadu (74%). Andhra Pradesh and West Bengal contributed 
to 15.5% and 6.6% of patients respectively (Table 1).    
 
COMORBID CONDITIONS 
1) DIABETES MELLITUS:  
30 (33.3%) out of 90 patients in this study were diabetics (Figure 3). In the internal jugular group, 
36% of patients were diabetics whereas in the femoral group 30 % had diabetes mellitus.   
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Fig. 3: Percentage of Patients with Diabetes Mellitus  
 
2) HYPERTENSION 
 
                          Fig. 4: Percentage of patients with hypertension 
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34% of the patients in this study had essential hypertension (Figure 4). 
The femoral group had a lower proportion of patients with essential hypertension as compared to 
the internal jugular group (30% versus 38%).  
 
 
3) CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) :  
 
 
      Fig. 5: Percentage of patients with chronic obstructive pulmonary disease  
 
Among 90 patients included in this study, 9 patients (10%) had chronic obstructive pulmonary 
disease (Figure 5).  
4 patients (9%) in the internal jugular group had chronic obstructive pulmonary disease as 
compared to 5 patients (11%) in the femoral group. 
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4) CHRONIC KIDNEY DISEASE (CKD)  
 
 
 
               Fig. 6: Percentage of patients with chronic kidney disease  
 
In this study, 8 (9%) out of 90 patients had chronic kidney disease (Figure 6).  
 
The femoral group had a lower proportion of patients with chronic kidney disease as compared to 
the internal jugular group (4 % versus 13 % respectively).   
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ADMISSION DIAGNOSIS  
 
 
Fig. 7:  Admission diagnosis of the patients included in the study 
 
 
Most of the patients included in the study were admitted with a diagnosis of sepsis syndrome 
(36.7%) (Figure 7) 
 
22 patients (24.4%) had an admission diagnosis of poisoning and 8 patients (8.9%) were admitted 
with history of non ST elevation myocardial infarction.   
Others: The diagnosis of patients under this category is included in appendix IV. 
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Table 2: Profile of patients with sepsis syndrome 
Pneumonia 10 (30.3%) Infective Exacerbation 
 of COPD  
2 (6.1 %) 
No definite focus 
of infection* 
6 (18.1%) Meningitis  
 
2 (6.1%) 
Scrub Typhus 5 (15.1%) Infective endocarditis  
 
1 (3 %) 
Pyelonephritis  4 (12.1%) Dengue 
 
1 (3 %) 
Skin and Soft Tissue 
 Infections 
2 (6.1 %)   
 
   
*there were no localizing features  
 
Among the patients with sepsis, 10 patients (30.3%) had pneumonia (Table 2). 
 
6 patients (18.1%) did not have definite localizing features or focus of infection at  
admission.  4 patients (12.1%) were diagnosed to have pyelonephritis.  
  
 
  
 
There were 2 patients with skin and soft tissue infections. One patient had cellulitis and  
the other patient had necrotizing fasciitis. There were 2 patients with pyogenic 
 meningitis and 2 patients with infective exacerbation of chronic obstructive pulmonary 
 disease.   
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Table 3: Profile of Poisoning patients  
Organophosphorus 18  Amitriptylene 1 
Nitrobenzene 1  Carbamazepine 1 
Oduvanthalai 1   
 
Among the patients with poisoning, 18 (81.8%) out of 22 patients had history of consumption of 
organophosphorus compounds (Table 3). There were 2 patients admitted with drug overdose. 
One patient had history of consumption of amitriptylene and the other patient had consumed 
carbamazepine tablets.  
 
Table 4: Admission diagnosis of patients in the internal jugular and femoral group 
 INTERNAL JUGULAR FEMORAL 
SEPSIS SYNDROME 15 (34%) 18 (39.1%) 
POISONING 9 (20.4%) 13 (28.2%) 
ACUTE CORONARY  
SYNDROME (NSTEMI) 
6 (13.6%) 2 (4.3%) 
OTHERS 14 (31.8%) 13 (28.2%) 
TOTAL 44 46 
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The femoral group had a higher proportion of patients with sepsis syndrome as compared to the 
internal jugular group. (39.1% versus 34.1%) (Table 4). Patients with poisoning were also more 
in the femoral group than the jugular group. (28.2 % versus 20.4%) 
 
 
APACHE II SCORE 
 
Table 5: APACHE II score of patients in the internal jugular and femoral groups 
 INTERNAL JUGULAR FEMORAL 
MEAN APACHE II SCORE 19.93 19.62 
STANDARD DEVIATION 6.713 6.043 
MINIMUM SCORE 8 9 
MAXIMUM SCORE 33 35 
 
The mean APACHE II score (Appendix III) in the jugular group and femoral group were 
similar (19.93 versus 19.62) (Table 5). The scores ranged from 8 to 33 in the jugular 
group and from 9 to 35 in the femoral group.  
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INDICATION OF CENTRAL VENOUS CATHETER INSERTION 
 
 
 
Fig 8: Indication of central venous catheter insertion  
 
The most common indication for insertion of central venous catheters was hemodynamic 
instability in both groups (63%) (Figure 8). 
Central venous catheter insertion was performed in anticipation of worsening of the patient’s 
condition in 27.7% and lack of a peripheral venous access in 7.7%. Central venous catheter 
insertion was done for 1 patient in the internal jugular group as the patient required continuous 
sodium bicarbonate infusion.  
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DAYS OF HOSPITAL STAY PRIOR TO CATHETER INSERTION 
 
The mean number of days of hospital stay prior to central venous catheter insertion was 4.2 days 
in the internal jugular group and 2.5 days in the femoral group.  
MECHANICAL VENTILATION 
 
 
      Fig. 9: Mechanical ventilation in the internal jugular and femoral group. 
 
Among 90 patients included in the study, 80 (88.88%) patients required invasive ventilation 
(Figure 9). 42 patients (91.3%) required invasive ventilation (intubation) in the femoral group as 
compared to 38 (86.3%) patients in the internal jugular group. The percentage of patients 
requiring mechanical ventilation was higher in the femoral group.  
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TRACHEOSTOMY  
 
Table 6: Patients with and without tracheostomy in the internal jugular and femoral 
groups 
TRACHEOSTOMY INTERNAL JUGULAR FEMORAL 
YES 8 (18%) 18 (39%) 
NO 36 (82%) 28 (61%) 
 44 46 
 
Among 90 patients included in this study, 26 patients (29%) had a tracheostomy during the 
course of their hospital stay. A higher proportion of patients in the femoral group had a 
tracheostomy during the course of their hospital stay as compared to the internal jugular group 
(39% versus 18%) (Table 6).  
 
 The presence of a tracheostomy is a potential source of infection for the internal jugular central 
venous catheter. In this study, 8 patients in the internal jugular group had a tracheostomy during 
the course of their hospital stay. However, 4 out of these 8 patients had a tracheostomy in situ 
during the period in which the internal jugular central venous catheter was present. Among these 
patients, colonization of the central venous catheter tip was seen in 1 patient. (25%) 
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PATIENTS REQUIRING INOTROPIC SUPPORT 
 
Table 7: Patients requiring inotropic support in the internal jugular and the femoral 
group  
 INTERNAL JUGULAR FEMORAL 
REQUIRED INOTROPES 9 (21.4%) 11 (23.9%) 
DID NOT REQUIRE 
 INOTROPES 
33 (78.5%) 35(76.08%) 
 42 46 
 
 
In the internal jugular group, 9 (21.4%) patients were on inotropes. In the femoral group, 13 
(23.9%) patients required inotropic support (Table 7). Data for 2 patients was not available.    
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PATIENTS REQUIRING ARTERIAL CATHETER INSERTION: 
 
 
Fig 10: Patients requiring arterial catheters in the internal jugular and femoral groups 
 
45 patients in this study required insertion of a radial or femoral arterial catheter for 
hemodynamic monitoring.  
In the internal jugular group, 19 patients (44.1 %) required insertion of an arterial catheter. In the 
femoral group, 26 (56%) of patients underwent insertion of arterial catheter. A higher proportion 
of patients in the femoral group required insertion of arterial catheter as compared to the internal 
jugular group.  
 
Data for 1 patient in the internal jugular group was not available.  Overall, 50.5 % of patients in 
this study required insertion of an arterial catheter also along with a central venous catheter.  
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Among the 3 patients who developed central line related bloodstream infection, 2 patients had an 
arterial catheter.    
 
 
REASON FOR REMOVAL OF CENTRAL VENOUS CATHETERS 
 
.  
Fig 11: Reason for removal of central venous catheters 
Central venous catheters were removed when they were not indicated. Suspicion of a catheter 
related infectious complication, presence of mechanical complications like deep vein thrombosis 
and misplacement of the catheter were other indications for removal. In patients who had expired, 
the central venous catheter was removed (Figure 11). 
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This was the most common reason for removal in the internal jugular as well as the femoral 
group (Figure 12).  
25 catheters (27.7%) were removed because a catheter related bloodstream infection was 
suspected. One patient in the femoral group had developed deep vein thrombosis following which 
the catheter was removed.  
A higher number of femoral catheters as compared to internal jugular catheters were removed as 
CRBSI was suspected. One patient in the internal jugular group was discharged at request and 
transferred home. His catheter was removed prior to discharge.  
 
Fig 12: Reason for catheter removal in internal jugular and femoral groups 
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DURATION OF CENTRAL VENOUS CATHETER  
 
The average duration that the central venous catheter was in situ was 6.66 days (Standard 
Deviation 2.72) in the internal jugular group. This varied from a minimum of 2 days to a 
maximum of 15 days.  
In the group with femoral central venous catheters, the mean duration of catheters was 
6.41 days (Standard deviation 2.35). The minimum number of days in this group was 2 
days and the maximum number of days was 15 days 
 
PRIMARY OUTCOME 
 
Table 8: Colonization in the internal jugular and femoral group    
 COLONIZATION PRESENT NO COLONIZATION 
INTERNAL JUGULAR N=44 9 (20.5%) 35 (79.5%) 
FEMORAL        N = 46 11(23.9%) 35 (76.1%) 
TOTAL             N = 90 20 (22.2%) 70 (77.8%) 
 
Among the 44 patients in the group with internal jugular catheters, 9 patients (20.5%) had 
colonization of the central venous catheter tip. Among the 46 patients in the group with 
femoral central venous catheters, 11 patients (23.9%) were found to have colonization of 
the central venous catheter tip. Overall, 90 patients were included in the study and 
catheter tips were found to have colonization for 20 (22.2%) of these patients (Table 8). 
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There was no significant difference between the internal jugular and the femoral group 
with respect to catheter tip colonization. The p value was 0.802 with confidence interval 
of 0.451 to 3.315. Odds ratio of colonization of femoral catheter tips as compared to 
internal jugular was 1.22. However, more patients need to be included in the study to 
draw clinical implications.  
The rate of colonization in the internal jugular group was 31.5 per 1000 catheter days and in the 
femoral group was 36.6 per 1000 catheter days.   Overall the catheter tip colonization rate in this 
study was 33.99 per 1000 catheter days. 
Out of the catheter tips which were found to be colonized, 45% belonged to the internal jugular 
group and 55% belonged to the femoral group.  
 
SECONDARY OUTCOME 
 
Table 9: CRBSI in the internal jugular and femoral groups 
          HAD CRBSI DID NOT HAVE CRBSI 
INTERNAL JUGULAR   N = 44               0            44 (100%) 
FEMORAL    N = 46           3 (6.5%)            43 (93.5%) 
TOTAL        N = 90           3 (3.3%)            87 (96.7%) 
 
There were 3 catheter related bloodstream infections (CRBSI)  among the patients included in 
this study. All catheter related bloodstream infections occurred in the group with femoral central 
venous catheters (Table 9). The catheter related bloodstream infection rate (CRBSI) rate in this 
study was 5.099 per 1000 catheter days.  
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The difference in the rates of catheter related bloodstream infection among the 2 groups was not 
significant. The p value was 0.242.  
However, there was a trend towards a higher rate of catheter related bloodstream infections in the 
group with femoral central venous catheters.  
 
BACTERIOLOGICAL PROFILE  
 
COLONIZATION  
 
 
 
Fig 13: Bacteriological profile – Colonization  
 
Acinetobacter was the most common organism (50%) that was isolated from colonized central 
venous catheter tips (Figure 13).   
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Multiple organisms were isolated from 4 (20%) patients. In these patients, Acinetobacter was 
isolated from 3 patients (Table 10).  
 
Candida tropicalis was isolated in 2 patients and Candida parapsilosis in 1 patient.  
Klebsiella, and coagulase negative Staphylococcus were isolated from 1 patient each. Non 
fermenting Gram negative bacilli was isolated from the catheter tip of 1 patient.  
 
Gram negative organisms were isolated from the majority (80%) of central venous catheter tips. 
Fungal infection accounted for 25% and Gram positive organisms were isolated from only 5% of 
colonized central venous catheter tips.  
 
  
Table 10: Bacteriological Profile of patients – Multiple organisms 
Patient 1 Acinetobacter and Enterococcus 
Patient 2 Acinetobacter and Klebsiella 
Patient 3 Acinetobacter, Coagulase negative Staphylococcus, Enterococcus and Providentia 
Patient 4 Escherichia coli, Enterococcus and Coagulase negative Staphylococcus  
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NFGNB = Non fermenting Gram negative bacilli  
CONS = Coagulase negative Staphylococcus  
Fig 14: Bacteriological profile in internal jugular and femoral central venous catheters 
 
A higher proportion of femoral catheters were colonized with multiple organisms (Figure 14). 
This may be due to proximity of femoral central venous catheters to the perineal region. 
 
CATHETER RELATED BLOODSTREAM INFECTION 
 
Klebsiella was isolated from 2 patients and Enterococcus isolated from 1 patient with catheter 
related bloodstream infection (Figure 15). The catheter tip of the patient with Enterococcus 
infection had grown multiple organisms including Acinetobacter. All the patients with catheter 
related bloodstream infections had femoral catheters.  
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Fig 15: Bacteriological Profile - CRBSI   
 
PROFILE OF PATIENTS WITH CRBSI  
 
Patient 1:  
 
This 56 year old lady was admitted with history of consumption of organophosphate 
(chlorpyrifos compound). She developed intermediate syndrome and hypotension for which she 
required mechanical ventilation and inotropic support. Her hospital course was complicated by 
the fact that she developed a non ST segment myocardial infarction during the course of her 
hospital stay. She developed CRBSI due to Enterococcus and was treated with meropenem and 
vancomycin injections. She was discharged in a stable state. Duration of ICU stay was 20 days 
and duration of hospital stay was 32 days.  
Klebsiella 
67% 
Enterococcus 
33% 
N = 3 
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Patient 2: 
   
This 40 year old man had chronic calcific pancreatitis and secondary diabetes and had presented 
with history of binge drinking and hypoglycemia. He required intubation and mechanical 
ventilation for low sensorium. He developed Klebsiella CRBSI for which he was treated with 
cefoperazone-sulbactam injections for 2 weeks. He was stable at discharge. Duration of hospital 
stay and ICU stay were 27 days and 9 days respectively.  
 
Patient 3:  
 
35 year old man presented with history of consumption of organophosphate (chlorpyrifos along 
with cypermethrin). He required intubation and mechanical ventilation for impending respiratory 
failure. He developed catheter related bloodstream infection secondary to Klebsiella which was 
sensitive to amoxicillin, gentamicin, cotrimoxazole, cefpodoxime. He was initiated on 
meropenem injections. His hospital course was complicated by upper gastrointestinal bleed 
secondary to gastric ulcer and acute renal failure requiring hemodialysis. He succumbed to his 
illness after 20 days of ICU treatment.  
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ANTIBIOTIC SUSCEPTIBILITY PATTERN  
 
GRAM NEGATIVE ORGANISMS  
 
Among 18 Gram negative organisms isolated from catheter tips, 15 (83.3%) were carbapenem 
resistant organisms. Acinetobacter was isolated from 13 catheter tips, of which 12 (92%) were 
resistant to carbapenems.  
 
GRAM POSITIVE ORGANISMS 
 
Gram positive organisms were isolated from 6 catheter tips. Coagulase negative Staphylococcus 
and Enterococcus were isolated from 3 catheter tips each.  
All isolates of Coagulase negative Staphylococcus were resistant to oxacillin.  
2 out of 3 Enterococcus isolates were susceptible to ampicillin, gentamicin, vancomycin, 
linezolid and teicoplanin. 1 patient had catheter tip colonization with Enterococcus that was 
resistant to ampicillin and gentamicin, but susceptible to linezolid, teicoplanin and vancomycin. 
  
LENGTH OF HOSPITAL STAY 
 
The mean duration of hospital stay was 18.19 days across both groups.  
In the Internal jugular group, patients were admitted for 19.93 days (SD 21.528) whereas in the 
femoral group the mean duration of hospitalization was 16.5 days. (SD 11.804). 
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LENGTH OF ICU STAY 
 
The mean duration of stay in the Intensive Care Unit was 13.3 days (SD 22.1) in the internal 
jugular group and 11.80 days (SD 7.57) in the group with femoral central venous catheters.  
 
MORTALITY 
 
Among the 90 patients who were included in the study, 24 (26.9%) patients died.   
 
Table 11: Mortality in the internal jugular and femoral groups 
MORTALITY→ NUMBER  PERCENTAGE 
INTERNAL JUGULAR 11 / 44  25% 
FEMORAL 13 / 45  28.8% 
TOTAL 24 / 89  26.9% 
 
 In the group with internal jugular central venous catheters, 25 % of the patients died as compared 
to 29.5% in the femoral group (Table 11). 1 patient with a femoral catheter was discharged at 
request. 
 
This difference in mortality rates across different sites of central venous catheter insertion was 
not statistically significant. (p value 0.520, confidence interval 0.274 to 2.694)   
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Table 12: Mortality in patients with and without catheter tip colonization 
MORTALITY→ NUMBER  PERCENTAGE 
COLONIZATION PRESENT 5 / 20 25% 
NO COLONIZATION 19 / 70   27.1% 
 
The mortality rate in patients with colonization was 25% as compared to 27.1% in those without 
colonization of the catheter tip (Table 12). 
This difference was not statistically significant ( p value 0.520, confidence interval 0.274-2.694). 
 
Table 13: Mortality in patients with and without catheter related bloodstream infection 
(CRBSI) 
 
MORTALITY→ NUMBER  PERCENTAGE 
CRBSI PRESENT 1 / 3 33.3% 
NO CRBSI 23 / 87    26.4% 
 
The mortality rate was higher in patients with CRBSI compared to those who did not have 
CRBSI.(33% versus 26.4%). (Table 13). 
However, this difference was not statistically significant. (p value 0.620 ) 
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FACTORS AFFECTING THE RATE OF COLONIZATION 
 
1) OPERATOR EXPERIENCE 
 
The physicians performing central venous catheter insertions were divided into high, intermediate 
or low operator experience.  
Physicians who had performed insertion of more than 15 central venous catheter insertions at the 
specified site (internal jugular or femoral) were included in high operator experience group. 
Physicians who had performed more than 4 but less than or equal to 15 central venous catheter 
insertions in the specified site were included in the intermediate operator experience group. 
Physicians who had inserted only 4 or lesser number of central venous catheters at the specified 
site were included in the low operator experience category. Data for 2 central venous catheter 
insertions in the internal jugular group was not available. 
 
 Table 14: Percentage of catheters inserted by physicians with high, intermediate and low 
operator experience 
OPERATOR EXPERIENCE →       LOW  INTERMEDIATE        HIGH 
 INTERNAL JUGULAR  N = 42        12             25           5 
          FEMORAL  N = 46         11             26           9 
              TOTAL  N = 88    23 (25%)        51 (59.1%)     14 (15.9%) 
 
 
. 
91 
 
Most of the central venous catheter insertions (59.1%) were performed by physicians with 
intermediate experience. (Table 14) .This was similar in the jugular as well as the femoral group. 
 
Table 15: Colonization in high, intermediate and low operator experience groups.   
COLONIZATION→ 
CATHETERS WITH 
COLONIZATION 
 
PERCENTAGE 
LOW EXPERIENCE                  4 / 23           17.3% 
INTERMEDIATE EXPERIENCE                  12 / 51            23.5% 
HIGH EXPERIENCE                  4 / 14           28.6% 
 
Surprisingly, 17.3% of central venous catheters were found to have colonization in the group 
with low operator experience whereas 28.6% of central venous catheters were found to be 
colonized in the group with high operator experience.(Table 15)  
However, there was no statistically significant difference in colonization rates between different 
levels of operator experience. (p value 0.76) 
 
         Table 16: CRBSI in patients with low, intermediate and high operator experience.  
CRBSI    → CATHETERS WITH CRBSI TOTAL 
LOW EXPERIENCE                      1 / 21      4.7% 
INTERMEDIATE EXPERIENCE                      2 / 50       4%  
HIGH EXPERIENCE                      0 / 14       0% 
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There were 3 catheter related bloodstream infections among the patients included in this 
study.(Table 16)  2 infections were in the group with intermediate operator experience and 1 
infection was seen in the group with low operator experience. There were no catheter related 
bloodstream infections in the group with high operator experience.  
 
2) REGISTRAR VERSUS INTERN PERFORMING INSERTION OF THE CENTRAL 
VENOUS CATHETER:  
 
Table 17: Central venous catheters inserted by registrars and interns in the internal jugular 
and femoral groups 
     REGISTRAR            INTERN 
INTERNAL JUGULAR     34 (80.9%)            8 (19%) 
FEMORAL     33 (71.7%)           13 (28.2%) 
TOTAL     67 (76.1%)            21 (23.8%) 
 
In this study, 67 central venous catheter insertions were done by registrars and 21 insertions were 
done by interns (Table 17). Data was not available for 2 patients.  
In the internal jugular group, 34 (80.9%) central venous catheters were inserted by registrars and 
8 (19%) were inserted by interns. In the group with femoral central venous catheters, a higher 
proportion (28.2%) of catheters were inserted by interns.  
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Table 18: Colonization in the central venous catheters inserted by registrars and 
interns 
COLONIZATION     NUMBER PERCENTAGE 
REGISTRAR     16 / 67     23.8% 
INTERN      4 / 21     19% 
 
4 (19%) out of 21 central venous catheter insertions done by the interns were found to have 
colonization.  Out of the 67 central venous catheters inserted by registrars, 16 (23.9%) had 
colonization (Table 18). 
 
There was no statistically significant difference in colonization rates between central venous 
catheters inserted by registrars and interns. (p value 0.447) 
 
3) NUMBER OF ATTEMPTS AT CENTRAL VENOUS CATHETER INSERTION  
 
The mean number of attempts at central venous catheter insertion in the internal jugular catheter 
group was 1.26 (Standard deviation 0.544). The minimum number of attempts in this group was 
once, and the maximum was 3 attempts. Number of attempts could not be recorded for 2 patients 
in internal jugular group. 
The mean number of attempts at central venous catheter insertion in the femoral group was 1.35. 
(Standard deviation 1.066) The minimum number of attempts in the femoral group was once, and 
the maximum number of attempts was 7. Details on number of attempts at catheter insertion 
could not be recorded for 3 patients in this group. 
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Among the central venous catheters which were found to have colonization, the mean number of 
attempts was 1.25 (Standard deviation 0.716). The mean number of attempts was 1.31 (standard 
deviation 0.895) among the patients without colonization of the central venous catheter.  
There was no statistically significant difference in colonization rates with respect to the number 
of attempts at catheter insertion. (p value 0.623) 
 
4) ULTRASOUND GUIDANCE:  
 
In this study, all the central venous catheter insertions done in the internal jugular group were 
under ultrasound guidance. In the femoral group, 33 (80.4%) central venous catheter insertions 
were done with the help of ultrasound guidance whereas 10 (19.6%)  were done blindly, using 
anatomical landmarks. Details on whether central venous catheter insertion was done under 
ultrasound guidance or not was not available for 5 patients.  
 
Table 19: Colonization in central venous catheters inserted with and without 
ultrasound guidance 
COLONIZATION      NUMBER PERCENTAGE 
WITH ULTRASOUND GUIDANCE          16 / 75           21.3% 
WITHOUT ULTRASOUND GUIDANCE            2 / 10             20% 
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Among the central venous catheters which were inserted under ultrasound guidance, 21.3% were 
found to have colonization of the catheter tip. 20% of the central venous catheters inserted 
without ultrasound guidance were detected to have colonization (Table 19).  
 This difference was not found to be statistically significant. (p value 0.447) 
 
In this study, 3 patients, all of who were in the femoral group, developed catheter related 
bloodstream infection. Central venous catheter insertion was done under ultrasound guidance for 
all the 3 patients.   
 
5) PLACE OF CENTRAL VENOUS CATHETER INSERTION: 
  
Table 20: Percentage of catheters inserted in the Medical Intensive care Unit (MICU) 
and the Medical High Dependency Unit (MHDU) 
 INTERNAL JUGULAR  FEMORAL  TOTAL 
MICU                  16          16  32 (35.5%) 
MHDU                  28          30  58 (64.5%) 
 
In this study, central venous catheters were inserted in the Medical Intensive Care Unit and 
Medical High Dependency Unit.  
Among the patients included in the study, a higher proportion of central venous catheter 
insertions were done in the Medical High Dependency Unit as compared to the Medical Intensive 
Care Unit (63.6% versus 36.4%) (Table 20). This is probably because central venous catheter 
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insertion for many patients in Medical Intensive Care Unit had been done in the ward or 
Emergency Department prior to their transfer to ICU. 
 
Table 21: Colonization of central venous catheters inserted in the Medical Intensive 
care Unit (MICU) and the Medical High Dependency Unit (MHDU) 
COLONIZATION 
NUMBER 
      PERCENTAGE 
MHDU 
14 / 58 
            24.1% 
MICU 
6 / 32 
            18.8% 
 
 
The rate of colonization of central venous catheters was 24.1% in Medical High Dependency 
Unit and 18.8% in the Medical Intensive Care Unit (Table 21).  
This difference was not statistically significant.( p value 0.378) 
 
 
6) TIME OF CENTRAL VENOUS CATHETER INSERTION 
 
The time of day during which central venous catheter insertion was done was recorded. This was 
divided into 3 shifts – morning (8 AM to 4 PM), evening (4 PM to 10 PM) and the night shift (10 
PM to 8 AM).  This corresponds to the shifts for the registrars and interns.  
. 
97 
 
17 (19.7%) of central venous catheters included on this study were inserted during the morning 
shift, 31 (36%) were inserted during the evening shift, and 38 (44%) during the night shift. Data 
related to time of insertion of the central venous catheter was not available for 2 patients.  
 
Table 22: Time of insertion of internal jugular and femoral central venous catheters 
 MORNING SHIFT 
(8 A.M. – 4 P.M.) 
EVENING SHIFT 
(4 P.M. – 10 P. M.) 
NIGHT SHIFT 
(10 P.M. – 8 A.M.) 
INTERNAL JUGULAR 
N = 44 
     8 (19.0%)        14 (33.3%)       20 (47.6%) 
FEMORAL 
N = 44 
     9 (20.4%) 
 
        
       17 (38.6%) 
         
18 (40.9%) 
TOTAL 
N = 88 
 
     17 (19.7%) 
         
       31 (36%) 
        
      38 (44%) 
 
 
A higher number of central venous catheter insertions were done during the night shift (44%). 
This was consistent across both groups (Table 22).  
In the internal jugular catheter group, 47.6% of catheter insertions were done in the night shift, 
33.3% in the evening shift and 19% during the morning shift. In the group with femoral central 
venous catheter insertions, 40.9% of catheters were inserted during the night shift, 38.6% during 
the evening shift and 20.4% during the morning shift.  
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Table 23: Colonization in central venous catheter tips inserted in the morning, evening and 
night shifts 
COLONIZATION →          NUMBER      PERCENTAGE 
MORNING SHIFT 
(8 A.M. – 4 P.M.) 
           
          4 / 17  
           
           23.5% 
EVENING SHIFT 
(4 P.M. – 10 P. M.) 
           
          7 / 31 
           
           22.6% 
NIGHT SHIFT 
(10 P.M. – 8 A.M.) 
         
           8 / 38 
         
           21.1% 
 
The colonization rate for central venous catheters inserted in the morning, evening and night shift 
were 23.5%, 22.6% and 21.1% respectively (Table 23). 
 
There was no statistically significant difference in the colonization rate between central venous 
catheters inserted during the morning, evening and night shift.  
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SIDE OF CENTRAL VENOUS CATHETER INSERTION 
 
 Fig. 16: Side of Central venous Catheter Insertion 
The majority of central venous catheters were inserted in the right side (91.1%) (Figure 
16) 
 
                         INTERNAL JUGULAR                                  FEMORAL   
Fig. 17: Side of Central Venous Catheter Insertion in the Internal Jugular and femoral 
group  
82 (91.1) % 
 
8 (8.9%) 
N = 90 
RIGHT SIDED
LEFT SIDED
39 
(89%) 
5 
(11%) 
N = 44 
RIGHT
SIDED
LEFT
SIDED 43 
(94%) 
N = 46 
 
3 (6%) 
RIGHT
SIDED
LEFT
SIDED
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89% of central venous catheters in the jugular group were inserted in the right side. 94% of the 
femoral central venous catheters were right sided. The internal jugular group had a higher number 
of left sided central venous catheters as compared to the femoral group (11 % versus 6%) (Figure 
17)  
 
Table 24: Colonization of central venous catheters inserted in the right and left side  
COLONIZATION  →        NUMBER        PERCENTAGE 
RIGHT          16 / 82             19.5% 
LEFT           4 / 8              50% 
 
 
Out of the 82 central venous catheters inserted on the right side, 19.5% were found to have 
colonization of the central venous catheter tip.   
 
There were 8 left sided central venous catheters, of which 4 (50%) were found to have 
colonization of the central venous catheter tip.  
The rate of catheter tip colonization was higher in left sided central venous catheters as compared 
to right sided central venous catheters (50% versus 19.5%) (Table 24).  
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FEVER  
 
Among the 90 patients included in this study, 45 (51.1%) had at least 1 episode of fever 
with temperature greater than 101° F when the central venous catheter was in situ.  
Out of 45 patients with fever, catheter related bloodstream infection was found to be present in 3 
(6.66%) of patients. However, all the 3 patients with catheter related bloodstream infection had 
fever.  
 
DIABETES MELLITUS 
 
Among 30 diabetic patients who were part of the study, 6 patients (20%) were found to 
have colonization of the central venous catheter tip. Out of 60 patients included in this 
study who did not have diabetes mellitus, 14 patients (23.3%) were found to have 
colonization of the central venous catheter tip (Table 25). 
 There was no statistically significant difference between the colonization rates of the 
central venous catheter tip among patients with and without diabetes mellitus. (p value 
0.558)    
Table 25: Colonization of central venous catheters in patients with and without diabetes 
mellitus 
COLONIZATION →         NUMBER PERCENTAGE 
WITH DIABETES           6 / 30             20% 
WITHOUT DIABETES           14 / 60            23.3% 
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LOCAL EXAMINATION 
 
 
In this study, 3 patients had abnormalities on local examination.  
2 patients had tenderness at the catheter insertion site. 1 patient had redness and warmth at the 
insertion site. These 3 patients were in the femoral group.  
None of the patients who had abnormalities on local examination had catheter related 
bloodstream infection.  
However, 2 out of the 3 patients had colonization of the central venous catheter tip.  
Non fermenting Gram negative bacilli were isolated from the catheter tip of one patient.  
For the second patient, multiple organisms (Escherichia coli, Enterococcus, and coagulase 
negative Staphylococcus) were isolated from the central venous catheter tip.    
 
 
MECHANICAL COMPLICATIONS 
 
2 femoral catheters were associated with mechanical complications. 
One patient had hematoma formation at the insertion site of the catheter.  
The other patient developed deep vein thrombosis due to which the catheter had to be removed. 
 
In the internal jugular group, there were no mechanical complications.  
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DISCUSSION 
 
This study assessed the rate of colonization and catheter related bloodstream infections in internal 
jugular and femoral central venous catheters in patients admitted in Medical Intensive Care Unit 
and High Dependency Unit in a tertiary care hospital in South India.  
  
PRIMARY OUTCOME 
  
 
Out of 44 patients in the jugular group, 9 (20.5%) patients had catheter tip colonization. 
In the femoral group, 11 (23.9%) out of 46 patients had colonization of the catheter tip.  
 
Though the femoral group had a higher rate of colonization, this difference was not 
statistically significant. However, the number of patients studied was not adequate to 
derive conclusive results. More patients need to be included in the study to draw clinical 
implications.  
 
The overall colonization rate was 33.99 per 1000 catheter days. The colonization rate in 
the jugular and femoral groups were 31.5 per 1000 catheter days and 36.6 per 1000 
catheter days respectively.  
 
The colonization rate of central venous catheter tip in an Indian study published by Patil 
et al was 27.77 per 1000 catheter days.(60)  In another Indian study by Mathai et al, the 
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colonization rate of the central venous catheter tip was 10.43 and 5.23 per 1000 catheter 
days for internal jugular and subclavian venous catheters respectively. (6) However, this 
study has shown a higher colonization rate than previous data, reasons for which are not 
evident at this point.  
 
SECONDARY OUTCOME 
 
 
There were 3 catheter related bloodstream infections among the patients included in the 
study. All 3 infections were in the femoral group. 2 infections were due to Klebsiella and 
1 infection was caused by Enterococcus.  
There were no catheter related bloodstream infections in patients with internal jugular 
catheters.  
 
The catheter related bloodstream infection rate in this study was 5.099 per 1000 catheter 
days. The CRBSI rate in other Indian studies ranges from 2.79 to 8 per 1000 catheter 
days. (6,28)  
 
Catheter related bloodstream infection rate is the secondary outcome of the study. The 
study was not powered to detect a difference in catheter related bloodstream infection 
rate between the jugular and femoral groups. However, there is a trend towards higher 
number of catheter related bloodstream infections in the femoral group in spite of similar 
colonization rates.  
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Possible reasons include proximity of the femoral catheter to the perineal region leading 
to higher burden of organisms and subsequent catheter related infections.  
An observational study from our institution conducted in 2012 noted that an admission diagnosis 
of sepsis syndrome is a risk factor for developing catheter related infection. (unpublished data). 
The femoral group had a higher number of patients with sepsis than the jugular group (39% 
versus 34%) and this may have been a predisposing factor for the development of catheter related 
bloodstream infections in patients with femoral central venous catheters.   
 
 
MICROBIOLOGICAL PROFILE  
 
 
Gram negative bacilli were isolated from 80% of colonized central venous catheter tips. 
The most common organism causing colonization of central venous catheters is 
Acinetobacter species (50%). Gram positive organisms were isolated from a small 
percentage (5%) of colonized central venous catheter tips.  
 
This is consistent with other reports from India where Gram negative bacilli are the 
predominant pathogen causing catheter tip colonization. (6,41) . However, in Western 
countries, Gram positive organisms including coagulase negative Staphylococcus, 
Enterococcus and Staphylococcus aureus are the predominant pathogens. (39) 
 
Colonization and catheter related bloodstream infection secondary to Gram negative 
bacilli is usually acquired from the hands of healthcare workers. Emphasis on 
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handwashing and careful handling of central venous catheters can be implemented to 
reduce the rate of catheter related infectious complications.  
 
CATHETER INSERTION RELATED FACTORS 
 
 
There was no statistically significant difference in colonization rates noted with 
ultrasound guidance, time and place of central venous catheter insertion, number of 
attempts at insertion, and duration of the central venous catheter. However, other Indian 
studies have shown prolonged duration of central venous catheter and multiple insertion 
attempts to be associated with higher rates of catheter related infectious complications.(6) 
 
There was no association between operator experience or registrar versus intern 
performing insertion of the central venous catheter with catheter tip colonization rates. 
 In our study, there were 3 catheter related bloodstream infections. 2 occurred in the 
group with intermediate operator experience and 1 in the group with low operator 
experience. There were no catheter related bloodstream infections in the group with high 
operator experience. However, the number of catheter related bloodstream infections in 
this study is small and more patients need to be studied to draw clinical implications.  
However, several other studies have shown lower rates of catheter related complications 
with experienced operators 
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Left sided central venous catheters showed a trend towards a higher colonization rate compared 
to right sided catheters (50% versus 19.5%). Operators are trained and used to right sided catheter 
insertions. They are unfamiliar with left sided central venous catheter insertions and this may 
have led to a higher rate of infectious complications with left sided catheters.  
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LIMITATIONS  
 
One of the limitations is that the number of patients studied was not enough to draw clinical 
implications.  
Patients who underwent central venous catheter insertion in the ward or the emergency 
department prior to transfer to the Intensive Care Unit were not included in the study as 
adherence to sterile barrier precautions may not have been adequate.  
 
Catheter related bloodstream infection would have been the ideal end point. However, this was 
not feasible due to low rates of catheter related bloodstream infections.  
 
Catheter tips were not sent for culture for some of the patients in this study.   
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CONCLUSION  
  
o There was no significant difference in the colonization rate in internal jugular and femoral 
central venous catheters in critically ill patients.  
 
o There is a trend towards a higher rate of central line related bloodstream infections in the 
femoral group.  
 
However, interpretation of these results should be made keeping in mind that the number 
of patients studied was not enough. More patients need to be included in the study to draw 
clinical implications.  
 
o Gram negative bacilli were the most common organisms implicated in colonization and 
catheter related bloodstream infection. Gram positive organisms caused only a small 
percentage of infections.  
 
o Factors related to catheter insertion - ultrasound guidance during catheter insertion, 
number of attempts at insertion, operator experience, time of insertion did not influence 
the rate of colonization.  
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APPENDIX I  
INFORMED CONSENT FORM 
Study title: Comparison of the rate of colonization of femoral central venous catheters 
versus internal jugular central venous catheters in the Medical ICU and HDU 
Study pattern: randomized controlled trial  
Place of Study: Christian Medical College, Vellore 
PART I : INFORMATION SHEET 
Introduction: 
We are doing a study on central line related infections. 
A central line is a catheter / tube that is passed through a vein to end up in the heart or 
in one of the large veins returning blood to the heart. 
It is used to administer medicines and fluids in sick patients. 
Purpose of the research: 
Central lines can be inserted in the neck and the groin. 
Insertion of central line is associated with a small chance of complications including 
bleeding from an artery, infections, air in the chest, fluid in the chest, bleeding into or 
under the skin. 
Previous research studies have shown varying results and it is still not certain whether 
there is a difference in the central line infection rates inserted in the 2 sites. 
This is a study to compare the rates of infections due to central lines inserted in the neck 
and groin. 
Type of research intervention: 
The site of central line insertion (neck or groin) will be selected by chance as if tossing a 
coin. 
Participant selection: 
Patients who require central line insertion and are admitted to the MICU/MHDU will be          
enrolled in the study. 
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Procedures and protocol: 
We will collect information about you (i.e. age, existing medical conditions, present 
problems) at the time the line is inserted. 
The central line will be inserted by a trained doctor. It is a minor procedure done under 
local anaesthesia. After cleaning the skin with antiseptic solutions, injection will be given 
to numb the area so that you do not feel any pain.  
With the help of a needle, a guidewire will be passed into the vein. After that, the 
central line will be passed over the guidewire and the guidewire removed. 
The central line will be secured with the help of 2 stitches.   
We will monitor you for signs of infection (i.e fever, results of blood tests). If signs of 
infection are present, the tip of the central line will be sent to the laboratory for tests. 
This will tell us whether it is infected and the causative organisms.  
The results of the test will help us in choosing the medicine to treat you with. This is part 
of standard treatment followed in the Medical ICU/HDU. 
If you don’t have fever or other signs of infection when the central line is removed, then 
the central line tip will still be sent for culture . In this case, the expenses of the test will 
be covered by a special fund. 
In the event of death of the participant, the central line will be removed and sent to the 
laboratory for the test.  In this case, the expense of the test will be covered by a special 
fund. 
 Potential Benefits: 
There may not be any benefit for you but your participation is likely to help us find the 
answer to the research question which will benefit patients in future. 
Voluntary Participation: 
Your participation in this study is entirely voluntary. 
If you do not wish to participate in the study, you will be offered the treatment that is 
routinely offered in this hospital for the disease that you have. 
You are free to withdraw from the study at any time. This will not affect your treatment 
in any way. 
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PART II : CONSENT SHEET 
Study Title: Comparison of the rate of colonization of femoral central venous catheters 
versus internal jugular central venous catheters in the Medical ICU and HDU 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw from the trial. I 
agree to this access. However, I understand that my identity will not be revealed in any 
information released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
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Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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APPENDIX II - PROFORMA 
COMPARISON OF THE RATE OF COLONIZATION OF INTERNAL JUGULAR VERSUS FEMORAL CENTRAL 
VENOUS CATHETERS                   PART I : DATA ABSTRACTION FORM  (TO BE FILLED AT THE TIME OF CVC 
INSERTION) 
Name    Hospital Number  
Age   Serial Number*  
Sex        Male / Female  Date   
*  please write the number written on the envelope 
PATIENT RELATED FACTORS: Indication for catheter insertion (please circle if applicable): 
Hemodynamic instability Lack of peripheral venous access Anticipate worsening 
Pre existing medical Conditions: 
Diabetes mellitus Hypertension Chronic kidney disease COPD 
Site of CVC insertion: 
    Left  /  Right   Internal Jugular/ Femoral  
Has the patient received antibiotics before admission   Yes /  No 
Number of days of hospital stay prior to insertion of CVC    
Does the patient have fever (temperature ≥ 101 °C  Yes / No  
Admission Diagnosis   
 
Pulse Rate   Blood Pressure  
Respiratory rate  SpO2 (Room air)  
OPERATOR / PROCEDURE  RELATED FACTORS: 
Number of attempts          1               2             3  
Under USG guidance   Yes / No  Time of Insertion   _ _ : _ _          (HH:MM)    
Place of CVC insertion   Emergency Medicine Dept   /   MICU  /  MHDU  
CVC inserted by    Consultant  /  Registrar  / Intern  
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Total no. of CVCs inserted by the 
operator  
           <10         10 – 30          >30  
No of CVCs inserted at this site             <5          5 – 15          >15 
 
PART 2: DATA ABSTRACTION FORM (TO BE FILLED AT THE TIME OF CVC REMOVAL) 
Name    Hospital Number  
Age   Serial Number*  
Sex        Male / Female  Date   
Final Diagnosis :  
 
No. of CVC days : 
       ≤3       4 - 6        7 – 9       10 – 12        13 – 16         >16 
Reason for CVC removal (Please circle if applicable): 
CVC is no longer required Suspected catheter related infection The patient has expired 
CVC related complication Discharge against medical advice / at 
request 
CVC is in the wrong location 
Were there any immediate complications of CVC insertion: 
Pneumothorax Haemothorax Arterial puncture 
Hematoma Others (please specify) 
Local examination of the CVC insertion site (Please circle if applicable): 
Redness Warmth  Tenderness Purulent discharge 
 
 Did the patient have fever (temp ≥ 100.4 °C ) after CVC insertion till removal:  
 
Did the patient have chills : 
 
 Did the patient have hypotension after CVC insertion till removal : 
      Yes / No 
       Yes / No 
       Yes / No 
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If yes, then (please circle if applicable):  
Require fluid resuscitation Require inotropes Systolic BP≤90 mmHg Diastolic BP≤60 mmHg 
 
Please fill in the following (recent values): 
Total WBC count   Differential WBC count   
Procalcitonin   
 
 Any other evident 
source of infection:  
 
 Any positive cultures:  If yes , please mention the date __/__/__ 
and source  
No. of Colony Forming Units:  _________ 
 Did the patient also have an arterial line ?   
 
 If yes, the please mention the site  
 No. of days of arterial line                           
 
 
 
 
 
 
 
 
 
Sputum Urine  Collections/abscesses Others  
 
Yes / No 
         Yes / No 
Radial / Femoral  
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APPENDIX III - The APACHE II Severity of Disease Classification System 
Physiologic Variable High Abnormal Range                                                      Low Abnormal Range 
  +4 +3 +2 +1 0 +1 +2 +3 +4 Point
s 
Temperature - rectal (°C) >41° 39 to 
40.9° 
  38.5 to 
38.9° 
36 to 
38.4° 
34 to 
35.9° 
32 to 
33.9° 
30 to 
31.9° 
<29.9°   
Mean Arterial Pressure - mm Hg >160 130 to 
159 
110 to 
129 
  70 to 
109 
  50 to 69   <49   
Heart Rate (ventricular response) >180 140 to 
179 
110 to 
139 
  70 to 
109 
  55 to 69 40 to 54 <39   
Respiratory Rate 
(non-ventilated or ventilated) 
>50 35 to 49   25 to 34 12 to 24 10 to 11 6 to 9   <5   
Oxygenation:  
a. FIO2 >0.5 record A-aDO2 
b. FIO2 <0.5 record PaO2 
>500 350 to 
499 
200 to 
349 
  <200 
  PO2>70 
   
  
 PO2 61 
to 70 
 
    
 PO2 55 to 
60  
  
 PO2<55  
  
Arterial pH (preferred)  
  
Serum HCO3 (venous mEq/l) 
(not preferred, but may use if no ABGs) 
>7.7 
  
  
>52 
7.6 to 
7.69 
  
41 to 
51.9 
  7.5 to 
7.59 
  
32 to 
40.9 
7.33 to 
7.49 
  
22 to 
31.9 
  7.25 to 
7.32 
  
18 to 21.9 
7.15 to 
7.24 
  
15 to 17.9 
<7.15 
  
  
<15 
  
Serum Sodium (mEq/l) >180 160 to 
179 
155 to 
159 
150 to 
154 
130 to 
149 
  120 to 
129 
111 to 
119 
<110   
Serum Potassium (mEq/l) >7 6 to 6.9   5.5 to 
5.9 
3.5 to 
5.4 
3 to 3.4 2.5 to 2.9   <2.5   
Serum Creatinine (mg/dl) 
Double point score for acute renal 
failure 
>3.5 2 to 3.4 1.5 to 
1.9 
  0.6 to 
1.4 
  <0.6       
Hematocrit (%) >60   50 to 
59.9 
46 to 
49.9 
30 to 
45.9 
  20 to 29.9   <20   
White Blood Count (total/mm3) 
(in 1000s) 
>40   20 to 
39.9 
15 to 
19.9 
3 to 14.9   1 to 2.9   <1   
Glasgow Coma Score (GCS) 
Score = 15 minus actual GCS 
                    
A. Total Acute Physiology Score (sum of 12 above points)   
B. Age points (years) <44=0; 45 to 54=2; 55 to 64=3; 65 to 74=5; >75=6   
C. Chronic Health Points (see below)   
Total APACHE II Score (add together the points from A+B+C)   
5 points for nonoperative or emergency postoperative patients 
2 points for elective postoperative patients 
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APPENDIX IV – ADMISSION DIAGNOSIS – OTHERS/MISCELLANEOUS GROUP 
 
DIAGNOSIS NUMBER OF OF 
PATIENTS 
Sputum positive pulmonary tuberculosis 2 
Disseminated tuberculosis 1 
Tuberculous meningitis 3 
Hanging 3 
Pulmonary edema, chronic kidney disease 2 
Myasthenia gravis 1 
Status epilepticus 1 
Snake bite 1 
Heat stroke 1 
Gastrointestinal bleed, decompensated chronic liver disease 1 
Cervical myelopathy 1 
CNS vasculitis 2 
Corrosive Injury - oesophagus 1 
Cerebrovascular accident 3 
Acute pancreatitis 1 
Pre eclampsia 1 
Porphyria 1 
Hepatic Encephalopathy 1 
  
. 
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APPENDIX V –   LIST OF TABLES AND FIGURES 
Table 1: State wise distribution of patients  
Table 2: Profile of patients with sepsis syndrome 
Table 3: Profile of poisoning patients 
     Table 4: Admission diagnosis of patients in the internal jugular and femoral group 
Table 5: APACHE II score of patients in the internal jugular and femoral groups 
Table 6: Patients with and without tracheostomy in the internal jugular and femoral groups 
Table 7: Patients requiring inotropic support in the internal jugular and the femoral group  
Table 8: Colonization in the internal jugular and femoral group   
Table 9: CRBSI in the internal jugular and femoral groups 
     Table 10: Bacteriological Profile of patients – Multiple organisms 
     Table 11: Mortality in the internal jugular and femoral groups 
     Table 12: Mortality in patients with and without colonization 
     Table 13: Mortality in patients with and without catheter related bloodstream infection 
(CRBSI) 
     Table 14: Percentage of catheters inserted by physicians with high, intermediate and low 
operator  experience 
     Table 15: Colonization in high, intermediate and low operator experience groups.   
     Table 16: CRBSI in patients with low, intermediate and high operator experience 
     Table 17: Central venous catheters inserted by registrars and interns in the internal jugular and    
femoral groups 
     Table 18: Colonization in the central venous catheters inserted by registrars and interns 
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     Table 19: Colonization in central venous catheters inserted with and without ultrasound                                                                
guidance 
Table 20: Percentage of catheters inserted in the Medical Intensive care Unit (MICU) and 
the Medical High Dependency Unit (MHDU) 
       Table 21: Colonization of central venous catheters inserted in the Medical Intensive care 
Unit (MICU) and the Medical High Dependency Unit (MHDU) 
        Table 22: Time of insertion of internal jugular and femoral central venous catheters 
        Table 23: Colonization in central venous catheter tips inserted in the morning, evening and 
night shifts 
        Table 24: Colonization of central venous catheters inserted in the right and left side  
        Table 25: Colonization of central venous catheters in patients with and without diabetes 
mellitus 
 
Figure 1: Age distribution of patients in the jugular and femoral group. 
Figure 2: Sex Distribution in the internal jugular and femoral groups 
Figure 3: Percentage of patients with Diabetes Mellitus  
      Figure 4: Percentage of patients with hypertension 
Figure 5: Percentage of patients with chronic obstructive pulmonary disease  
      Figure 6: Percentage of patients with chronic kidney disease  
Figure 7:  Admission diagnosis of the patients included in the study 
Figure 8: Indication of central venous catheter insertion  
      Figure 9: Mechanical ventilation in the internal jugular and femoral group. 
Figure 10: Patients requiring arterial catheters in the internal jugular and femoral groups 
Figure 11: Reason for removal of central venous catheters 
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Figure 12: Reason for catheter removal in internal jugular and femoral groups 
     Figure 13: Bacteriological profile – Colonization  
     Figure 14: Bacteriological profile in internal jugular and femoral central venous catheters 
     Figure 15: Bacteriological Profile - CRBSI   
     Figure 16: Side of Central venous Catheter Insertion 
     Figure 17: Side of Central Venous Catheter Insertion in the Internal Jugular and femoral group  
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UNIT APACHE SCORE SEX SITE J/F FINAL DX SIDE L/R TIP C/S CFUTIP C/S ORGANISM DOLI DOLR
PULM MED 28 2 2 SPUTUM POSITIVE PULMONARY TUBERCULOSIS / DRUG INDUCED HEPATITIS / LV DYSFUNCTION / HYPOTHYROIDISM / HYPOVITAMINOSIS D1 0 19-02-14 20-Feb
NEPHROLOGY 1 31 2 1 ACUTE KIDNEY DISEASE PROGRESSING TO CHRONIC KIDNEY DISEASE 1 0 0 20-07-14 27-02-14
MEDICINE 4 21 2 2 MENINGOENCEPHALITIS / SEPTIC SHOCK / VENTILATOR ASSOCIATED PNEUMONIA 2 SCANTY NFGNB 02-03-14 04-03-14
MEDICINE 4 11 2 1 OP POISONING / INTERMEDIATE SYNDROME / CATHETER RELATED BLOODSTREAM INFECTION - KLEBSIELLA 1 4 KLEBSIE LA PANSENSITIVE / PSEUDOMONAS AERUGINOSA PANSENSITIVE05-03-14 10-03-14
MEDICINE 2 23 2 2 AMITRYPTILENE OVERDOSE / DYSTHYMIA / DYSELECTROLYTEMIA 1 0 10-03-14 12-03-14
MEDICINE 1 19 2 2 CARBAMAZEPINE OVERDOSE SPUTUM POSITIVE PULMONARY TB ATT INDUCED HEPATITIS1 0 09-03-14 17-03-14
MEDICINE 3 16 1 2 OP POISONING - MONOCROTOPHOS / IMTERMEDIATE SYNDROME / VENTILAR ASSOCIATED PNEUMONIA1 0 09-03-14 15-03-14
MEDICINE 1 31 1 2 MRSA PNEUMONIA WITH SEPTIC SHOCK 1 0 13-03-14 22-03-14
MEDICINE 3 10 2 2 OP POISONING - CHLORPYRIPHOS 2 0 17-03-14 23-03-14
MEDICINE 2 35 1 2 KLEBSIELLA PNEUMONIA / VENTILATOR ASSOCIATED PNEUMONIA / SEIZURE DISORDER / 1 150 / 4 NFGNB SENSITIVE TO COLISTIN RESISTANT TO OTHERS / KLEBSIELLA PANREISTANT01-04-14 08-04-14
MEDICINE 1 8 2 1 PNEUMONIA BIBASAL CONSOLIDATION / SEPTIC SHOCK 1 0 15-04-14 23-04-14
NEUROLOGY 15 1 2 COMLETE HANGING / ALCOHOL INTOXICATION / DELIBERATE SELF HARM 1 0 08-05-14 09-05-14
NEUROLOGY 22 1 2 MYAESTHENIA GRAVIS 1 0004/01 KLEBSIELLA + PROTEUS VULGARIS18-05-14 27-05-14
GASTRO 26 1 1 CLD?NAFLD?CRYPTOGENIC VARICEAL BLEED POST EVL ACUTE ON CKD 1 0 26-05-14 01-06-14
MEDICINE 4 12 2 2 SYSTEMIC ARTERIAL HYPERTENSION / PYELONEPHRITIS / HYPOTHYROIDISM / DYSELECTROLYTEMIA / VITAMIN B12 DEFICIENCY1 0 31-05-14 03-06-14
MEDICINE 2 18 1 2 SEPTIC SHOCK 1 0 26-03-14 29-03-14
MEDICINE 1 20 1 2 OP POISONING DVT 2 UPPER LIMB PROVOKED MSSA BACTEREMIA VAP 1 0 30-03-14 04-04-14
MEDICINE 2 12 2 1 OP POISONING / PROFENOFOS / INTERMEDIATE SYNDROME / GRAM NEGATIVE BACTEREMIA / PROBABLE FOCAL SEIZURES1 34 NFGN  PANRESISTANT SENTIVE ONLY TO COLISTIN16-04-14 21-04-14
MEDICINE 3 25 1 2 OP POISONING PROFENOPHOS VAP INTERMEDIATE SYNDROME 1 0 0 25-04-14 27-04-14
MEDICINE 1 28 1 1 DISCHARGED AT REQUEST - meningitis 1 0 26-04-14 28-04-14
MEDICINE 4 not available 1 1 ODUVANTHALAI POISONING 1 0 26-04-14 04-05-14
MEDICINE 5 9 2 1 SNAKE BITE 1 0 28-05-14 02-06-14
MEDICINE 1 14 1 1
TUBERCULOUS MENINGITISCHRONIC HEPATITIS B INFECTION
ATT INDUCED HEPATITS 1 0 20-05-14 27-05-14
MEDICINE 4 15 1 1 INFECTIVE ENDOCARDITIS MARFANS CEREBRAL PALSY ASPIRATION PNEUMONIA SEPTIC SHOCK  1 0 20-05-14 27-05-14
MEDICINE 2 18 1 1 PYELONEPHRITIS ECOLI ESBL DCLD PORTAL HTN 1 >1000 Candida tropicalis 07-01-14 09-01-14
MEDICINE 3 14 2 1 SEPTIC SHOCK / PARAPARESIS / NECTROTIZING FASCITIS RIGHT GLUTEAL REGION / PARANOID SCHIZOPHRENIA / HOSPITAL ACQUIRED PNEUMONIA1 0 10-01-14 18-01-14
NEUROLOGY 9 1 2 CRYPTOGENIC NEW ONSET STATUS EPILEPTICUS / RIGHT INTRAVENTRICULAR MENINGIOMA 1 0 10-01-14 18-01-14
PULM MED 28 1 1 ACUTE INFECTIVE EXACERBATION OF COPD 1 0 10-01-14 15-01-14
MEDICINE 1 17 2 1 SEPTIC SHOCK     1 0 23-12-13 27-12-13
MEDICINE 3 22 1 1 RHABDOMYOLYSIS - SECONDARY TO CHROMIUM INTOXICATION / MYOCARDITIS / HYPOVITAMINOSIS D1 0 11-01-14 18-01-14
MEDICINE 3 13 1 2 REFRACTORY SEPTIC SHOCK / SECONDARY ENTEROCOCCAL SEPSIS / PNEUMOCOCCAL PNEUMONIA / 1 0 12-01-14 16-01-14
MEDICINE 4 15 2 2 CNS VASCULITIS / AIHA / MYOCARDITIS / ENTEROCOCCAL SEPSIS / LEFT PNEUMOTHORAX POST ICD RESOLVED / 1 0 12-01-14 18-01-14
GERIATRIC 14 1 2 DILUTIONAL HYPONATREMIA/NSTEMI/ CAUDA EQUINA SYNDROME / CERVICAL MYELOPATHY / . DYSLIPIDEMIA/ OSA / OBSTRUCTIVE UROPATHY / PSORIASIS 1 SC NT YEAST 16-01-14 21-01-14
MEDICINE 1 20 1 2 SPUTUM POSITIVE PULMONARY TUBERCULOSIS 1 0 17-01-14 22-01-14
MEDICINE 1 24 1 1 SCRUB TYPHUS WITH ARDS 1 0 16-01-14 21-01-14
MEDICINE 3 33 1 1 PYELONEPHRITIS - RECURRENT INFECTION 1 0 16-01-14 24-01-14
PULM MED 27 1 2 INFECTIVE EXACERBATION OF COPD / NSTEMI / HYPOVITAMINOSIS-D 1 0 19-01-14 24-01-14
MEDICINE 3 19 2 1 SYSTEMIC LUPUS ERYTHREMOATOSUS / CNS AND RENAL INVOLVEMENT / FIBROAENOMA BREAST2 0 21-01-14 25-01-14
MEDICINE 3 15 1 1 CERVICAL CORD COMPRESSION C2 TO C6 / RECURRENT ASPIRATION PNEUMONIA / RIGHT BRONCHOPLEURAL FISTULA2 25 ONS 17-04-14 22-04-14
MEDICINE 2 21 1 1 OP POISONING HEACONAZOLE / INTERMEDIATE SYNDROME / NOSOCOMIAL PNEUMONIA1 200 NFGNB 25-02-14 31-01-14
MEDICINE 4 11 1 2 SCRUB TYPHUS DVT RIGHT LEG PROVOKED LV DYSFUNCTION 1 120 NFGNB 28-01-14 30-01-14
MEDICINE 3 23 1 1 REFRACTORY SEPTIC SHOCK / DYSLIPIDEMIA 1 0 29-01-14 10-02-14
GASTRO 18 2 2
CORROSIVE INJURY OESOPHAGUS / VAP / FEEDING JEJUNOSTOMY / IRON 
DEFICINECY ANEMIA 1 21 CANDIDA PARAPSILOSIS30-01-14 06-02-14
NEUROLOGY 16 2 1
DELIBRATE SELF HARM (HIGH INTENTIONALITY AND LETHALITY)
COMPLETE HANGING - POPE
PROBABLE ORGANIC PSYCHOSIS 2 0 30-01-14 02-02-14
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DAYS OF CVCINDICATION DM HTN CKD COPD ANTIBIOTICS BEFORE ADMISSIONDAYS OF HOSP STAY PRIOR TO CVC INSERTIONFEVER>101 C ADMI SION DX PR RR BP SPO2 NO OF ATTEMPTSUSG PLACE REGISTRAR/INTERNPAS  EXP - no. OF CVSTOTAL NUMBER OF CVC INSERTED AT THIS SITE  TIME  INSERTION 
2 1 0 0 0 0 ATT O/S 2 0 SPUTUM POSITIVE PULMONARY TUBERCULOSIS110 28 130/80 80 1 1 2 1 2 2 2
8 1 0 0 1 0 0 0 0 ACCELARATED HYPERTENSION110 GASPING 230/130 NR 1 1 2 1 2 2 2
3 1 0 0 0 0 1 0 1 MENINGOENCEPHALITIS110 22 88/60 100 INTUBATED 4 1 1 1 2 2 3
6 2 0 0 0 0 0 1 0 OP POISONING 120 30 120/60 96 1 1 1 1 2 2 3
3 3 0 1 0 0 0 0 0 AMITRYPTILENE POISONING99 24 130/80 82 1 1 1 1 2 2 1
10 2 0 0 0 0 0 3 0 DISSEMINATED TUBERCULOSIS88 16 110/60 96 1 0 1 1 2 2 3
7 1 0 1 0 0 0 0 0 OP POISONING MONOCROTOPHOS 125 20 150/90 98 1 0 2 1 2 2 3
10 1 1 0 0 1 1 3 1 COMMUNITY ACQUIRED PNEUMONIA140 BAGGING 80/50 99 INTUBATED 2 1 1 1 2 2 3
7 1 0 0 0 0 0 1 0 OP POISONING - CHLORPYRIPHOS100 20 110/70 98 2 1 1 1 2 2 3
8 1 1 0 0 0 0 1 1 COMMUNITY ACQUIRED PENUMONIA WITH SEPTIC SHOCK108 18 120/60 91 1 1 2 1 3 3 3
9 1 0 0 0 0 0 0 1 COMMUNITY ACQUIRED PNEUMONIA / SEPTIC SHOCK / SEIZURES UNDER EVALUATION153 46 80/60 88 2 1 2 1 2 2 2
2 1 0 0 0 0 0 0 0 COMPLETE HANGING 86 80/60 70 1 1 2 1 2 2   
10 2 0 0 0 0 1 9 0 MYAESTHENIA GRAVIS 112 32 100/60 95 1 1 2 1 1 1 2
7 4 1 1 1 0 0 3 0 GI BLEED 84 28 130/60 95 1 1 2 1 1 1 3
4 3 0 1 0 0 1 0 1 DYSELECTROLYTEMIA / ACUTE FEBRILE ILLENSS110 16 140/90 100 1 1 2 1 2 2 1
4 1 0 1 0 0 0 0 1 SEPTIC SHOCK 130 GASPING 170/100 80 1 1 1 2 1 1 1
6 2 0 0 0 0 1 7 1 OP POISONING COMPOUND 0T K0WN90 NA 110/60 NA 1 1 1 1 2 2 2
6 4 0 0 0 0 0 0 0 OP POISONING PROFENOFOS102 21 128/80 100 INTUBATED 1 1 1 1 1 1 1
3 3 0 0 0 0 0 0 1 OP POISONING 150 46 100/60 80 1 1 1 1 2 2 3
3 3 1 1 0 0 0 1 1 UTI 106 24 100/80 92 3 1 1 1 3 3 3
9 5 0 0 0 0 0 0 0 ODUVANTHALAI POISONING DSH110 20 110/60 96 1 1 1 1 1 1 3
6 1 0 0 0 0 0 0 0 SNAKE BITE NA NA NA NA    1   NA 3
8 1 0 0 0 0 ATT O/S 4 1 TUBERCULOUS MENINGITIS86 NA 95/50 NA 2 1 1 1 1 1 3
8 1 0 0 0 0 1- O/S 0T SURE 0 1 INFECTIVE ENDOCARDITIS   110 20 100/60 100 1 1 1 1 1 1 3
3 1 0 0 0 0 DOXY AZITHRO 6 0 ACUTE FEBRILE ILLNESS 94 44 160/80 87 1 1 1 1 1 2 2
9 1 1 0 0 0 0 0 1 CELLULITIS / SEPTIC SHOCK / DIABETIC KETOACIDOSIS100 30 70/50 96 1 1 1 1 2 2 3
9 3 1 0 0 0 1 5 1 SEIZURES UNDER EVALUATION112 23 102/68 100 1 0 2 1 3 3 1
6 1 1 1 0 1 0 1 1 COPD EXACERBATION 100 24 120/80 NR    2  NR NR  
5 1 1 1 0 0 0 0 0 SEPTIC SHOCK 110 34 80/60 79 1 1 2 1 2 2 1
8 1 0 0 0 0 1 DETAILS NOT KNOWN0 0 SEPTIC SHOCK / ACUTE KIDNEY INJURY124 36 90/50 90 2 1 1 2 1 1 1
5 1 0 0 0 1 0 1 1 COMMUNITY ACQUIRED PNEUMONIA / SEPTIC SHOCK / SEIZURES UNDER EVALUATION112 33 150/90 83 1 1 1 2 1 1 2
7 1 0 0 0 0 1 1 1 MENINGITIS / SEPTIC SHOCK138 36 80/50 88 1 0 1 1 3 3 2
6 1 1 1 1 1 0 1 0 SYMPTOMATIC HYPONATREMIA81 16 130/80 99 1 0 2 1 2 2 2
6 1 0 0 0 0 1 1 1 ?PULMONARY TB / ARDS 130 20 90/40 96 1 1 1 2 1 1 3
6 3 0 0 0 0 0 5 1 SCRUB TYPHUS 120 40 130/80 92 2 1 1 1 2 2 3
11 3 1 0 1 0 0 15 0 pyelonephritis 122 32 128/68 96 2 1 1 2 1 1 2
6 1 1 1 0 1 1 0 0 COPD EXACERBATION / NSTEMI 70 40 100/60 92 2 1 2 2 2 2 2
5 1 0 0 0 0 0 0 0 SYSTEMIC LUPUS ERYTHREMATOSUS110 26 100/60 86 1 1 2 1 2 2 2
6 1 0 0 0 0 1 82 1 ?WERNICKE S ENCEPHALOPATHY66 24 90/60 100 1 1 1 1 2 2 3
7 3 1 1 0 0 0 0 0 OP POISONING 84 NR 90/60 64 1 1 2 1 2 2 1
3 3 1 1 0 0 0 0 0 SCRUB TYPHUS 92 20 110/70 90 1 1 1 2 1 1 2
13 1 1 1 0 0 0 13 1 NSTEMI/CONGECTIVE CARDIAC FAILURE / PNEUMONIA 80 18 130/80 99 INTUBATED 1 1 2 2 2 2 2
8 3 0 0 0 0 0 1 0 CORROSIVE POISONING / OESOPHAGITIS140 40 120/80 ? 1 0 2 1 3 3 3
4 2 0 0 0 0 0 2 0 PARTIAL HANGING 97 18 117/76 98 1 1 2 1 3 3 3
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REASON FOR REMOVALCOMP L/E FEVER WITH CVCCHILLS HYPOTENSIONFUIDS/I0TROPESART LINE SIDE SITE DAYS ART LINECRBSI Y/N COLONIZATION Y/NDAYS ICU NUMBER OF DAYS HOSP STAYTRACHEOSTOMY DIED/ LIVEAGE
3 0 0 0 0 0 0 1 1 1 2 0 0 2 4 0 2 25
1 0 0 1 0 1 3 1 1 1 3 0 0 5 25 0 1 22
3 3 0 1  1 3 1 1 1 3 0 0 3 3 0 2 24
2 0 0 1  1 3 1 1 1 7 0 0 15 21 1 1 29
3 0 0 0 0 0 0 0 0 0 3 7 0 1 63
1 0 0 0 0 0 0 0 0 0 10 12 0 1 53
2 0 0 1 0 0 0 0 0 0 16 21 1 1 46
3 0 0 1 0 1 3 1 1 1 6 0 0 11 14 0 2 66
1 0 0 1 0 0 0 0 0 0 8 10 0 1 16
2 0 0 1  1 3 1 1 1 13 0 1 15 16 0 2 68
2 0 0 1 0 1 3 1 1 1 7 0 0 18 18 0 2 30
1 0 0 1 0 1 1 0 0 0 3 4 0 1 46
 0 0 0 0 0 0  0 0 ? ? 1 1 35
1 0 0 0 0 0 0 1 1 1 5 0 0 5 13 0 1 59
3 0 0 0 0 0 0 0 0 0 3 20 0 1 24
3 0 0 1 0 1 3 1 1 1 3 0 0 3 3 0 1 70
1 0 0 1 1 0 0 0 0 0 13 16 1 1 23
1 0 0 0 0 0 0 0 0 1 12 17 0 1 27
1 0 0 1 0 0 0 0 0 0 20 27 1 1 26
2 0 0 1 0 1 3 0 0 0 4 15 0 1 60
1 0 0 0 0 0 0 0 0 0 4 12 0 1 19
1 0  0 0 0 3 1 1 1 4 0 0 6 6 0 2 68
3 0 0 1 0 0 0 1 2 1 6 0 0 27 29 1 1 27
1 0 0 1 0 1 BOTH 1 1 1 5 0 0 28 35 1 2 36
1 0 0 0 0 1 FLUIDS 0 0 1 5 7 0 1 75
2 0 0 1 0 0 0 1 1 1 6 0 0 14 34 0 1 40
1 0 0 1 0 1 3 0 0 0 13 25 0 1 40
3 0 0    NR  0 0 6 10 0 2 59
1 0 0 0 0 0 0 1 1 1 5 0 0 5 7 0 1 57
1 0 0 1 0 0 0 0 0 0 9 27 0 1 22
2 0 0 1 0 1 3 1 1 1 5 0 0 11 11 0 2 75
2 0 0 1  1 3 1 RIGHT +LEFT 1 23 0 0 30 30 1 2 22
1 0 0 0 0 0 0 0 0 0 2 11 0 1 72
1 0 0 0 0 0 0 0 0 0 6 10 0 1 16
1 0 0 0 0 0 0 0 0 0 4 7 0 1 46
1 0 0 0 0 0 0 0 0 0 9 15 0 1 47
1 0 0 0 0 0 0 1 1 1 6 0 0 5 11 0 1 61
1 0 0 1 0 0 0 0 0 0 2 8 0 1 20
2 0 0 1 0 0 0 0 0 0 0 0 1 141 141 1 2 64
1 0 0 1 0 0 0 0 0 1 12 21 0 1 61
4 5 1 0 0 0 0 0 0 1 9 4 0 1 64
2 0 0 1 0 1 3 1 1 1 14 0 0 14 26 1 2 70
2 0 0 1 1 0 0 1 1 1 6 0 1 13 31 1 1 17
1 0 0 0 0 0 0 0 0 0 6 8 0 1 27
. 
130 
 
 
MEDICINE 2 not available 1 2
PROBABLE ORGANOPHOSPHORUS POISONING
INTERMEDIATE SYNDROME
DELAYED ORGANOPHOSPHORUS ENCEPHALOPATHY
E. Coli BACTEREMIA WITH SEPTIC SHOCK
PROBABLE ASPIRATION PNEUMONIA 1 150 NFGNB PANRESISTANT SENTIVE ONLY TO COLISTIN01-02-14 08-02-14
MEDICINE 1 14 1 2 OP POSONING ENTEROCOCCAL SEPSIS GASTRITIS REFRACTORY SHOCK 1 22 KLEBSIELLA PANSENSITIVE06-02-14 12-03-14
NEPHROLOGY 1 30 1 1 ACUTE ON CHRONIC KIDNEY DISEASE / VAP / ACUTE PULMONARY EDEMA 1 0 07-01-14 17-02-14
MEDICINE 2 18 1 1 SCRUB TYPHUS 1 0 09-02-14 11-02-14
MEDICINE 4 17 1 2 ACUTE FEBRILE ILLNESS 1 0 0 08-02-14 13-02-14
MEDICINE 3 20 1 1
ALCOHOL DEPENDENCE SYNDROME
HEPATIC ENCEPHALOPATHY
CLD ASPIRATION PNEUMONIA 1 120 NFGNB SENSITIVE TO COLISTIN RESISTANT TO OTHERS 24-08-13 31-08-13
MEDICINE 3 25 1 1 NSTEMI PULMONARY EDEMA ACUTE ON CHRONIC KIDNEY DISEASE 1 0 25-08-13 29-08-13
MEDICINE 1 15 1 1 CARBAPHOS POISONING 1 0 28-08-13 30-08-13
MEDICINE 3 11 1 2 NITROBENZENE POISONING 1 0 30-08-13 02-09-13
MEDICINE 4 15 2 1 SCRUB TYPHUS WITH SHOCK / AKI/ HYPOCORTISOLEMIA UNDER EVALUATION 1 0 02-09-13 04-09-13
MEDICINE 1 19 2 2 SCRUB TYPHUS WITH SHOCK / VAP/ ARDS 1 100 NFGNB SENSITIVE TO COLISTIN RESISTANT TO OTHERS 03-09-13 09-09-13
ENDOCRINOLOGY 26 1 2
CHRONIC CALCIFIC PANCREATITIS
SECONDARY DIABETES MELLITUS
HEAD INJURY
BILATERAL VOCAL CORD ADDUCTOR PALSY
DIABETIC NEPHROPATHY 
DIABETIC SENSORY NEUROPATHY
ALCOHOL DEPENDENCE SYNDROME
VITAMIN D DEFECIENCY
HYPONATREMIA - DEPLETIONAL
ANAEMIA - MULTIFACTORICAL 1 400 NFGNB KLEBSIELLA04-09-13 09-09-13
ENDOCRINOLOGY 21 2 1 CORONARY ARTERY DISEASE - TRIPLE VESSEL DISEASE / PAROXYSMAL ATRIAL FIBRILLATION / EXOGENOUS CUSHINGS SYNDROME / OSTEOARTHRITIS KNEE / OSTEOPENIA 1 0 27-09-13 04-10-13
MEDICINE 3 13 2 2 NSTEMI OP POISONING CHLORPYRIFOS INTERMEDIATE SYNDROME 1 733 CONS/NFGNB/PROVIDENCIA/ ENTEROCOCCUS06-10-13 15-Oct
MEDICINE 1 19 1 1
ORGANOPHOSPHATE POISONING
INTERMEDIATE SYNDROME 
DELAYED OP INDUCED ENCEPHALOPATHY 2 0 10-Oct 16-10-13
MEDICINE 4 18 2 2 OP POISONING PHORATE / VAP/ INTERMEDIATE SYNDROME 1 SCANTY CONS 09-10-13 19-10-13
NEUROLOGY 13 2 2 PARTIAL HANGING / POPE/  PARANOID SCHIZOPHRENIA 1 0 10-10-13 13-10-13
HAEMATOLOGY 22 1 2 H3N1 PNEUMONIA WITH MYOCARDITIS 1 0 15-10-13 20-10-13
MEDICINE 4 17 1 2 OP POISONING NEONICOTINOID / BILATERAL ADDUCTOR PALSY 1 0 23-10-13 30-10-13
MEDICINE 2 20 2 1 PHORATE POISONING VITAMIN B 12 DEFICIENCY 1 0 27-10-13 31-10-13
MEDICINE 2 21 1 2 LEFT LEG CELLULITIS AKI ?SECONDARY TO PSGN SEPTIC SHOCK 1 0 28-10-13 30-10-13
MEDICINE 4 32 1 1 ACUTE CORONARY SYNDROME / EXACERBATION OF COPD 1 0 30-10-13 31-10-13
MEDICINE 1 28 2 1 RHEUMATOID ARTHRITIS ILD H3NI PNEUMONIA HYPOTHYROIDISM 1 0 02-11-13 07-11-13
PULM MED 18 2 2 ILD SCLERODERMA MODS SEPTIC SHOCK PROBABLE VAP 1 0 03-11-13 10-11-13
MEDICINE 1 19 1 2 OP POISONING ETHION D2/VAP/SEPTIC SHOCK/ ESOPHAGEAL INTUBATION?HIE 1 SCANTY CONS 03-11-13 07-11-13
MEDICINE 2 15 2 1 OP POISONING METHYL PARATHION /DOPE/LEFT VOCAL CORD PALSY/CA UTI 1 460 Candida tropicalis 04-11-14 08-11-14
MEDICINE 2 19 1 1 PROBABLE TUBERCULOUS MENINGITIS 1 0 12-11-13 16-11-13
MEDICINE 3 23 1 2 COMMUNITY ACQUIRED PNEUMONIA / SEPSIS 1 0 18-11-13 23-11-13
MEDICINE 1 25 2 1 SEVERE PRE ECLAMPSIA / CA UTI / FLASH PULMONARY EDEMA WITH AKI/ VITAMIN B12 DEFICIENCY ANEMIA 1 130 NFG B 10-12-13 13-12-13
MEDICINE 3 20 1 1 HYPOXIC  ENCEPHALOPATHY CARDIOGENIC SHOCK NSTEMI 1 0 14-12-13 22-12-13
MEDICINE 1 25 1 2 SEPTIC SHOCK/  HYPOSTATIC PNEUMONIA/ BRONCHIAL ASTHMA 1 0 26-12-13 02-01-14
MEDICINE 1 11 2 1 IDIOPATHIC DILATED CARDIOMYOPATHY DM HTN ASTHMA 1 0 29-05-14 01-06-14
MEDICINE 5 20 2 2 CVA/HONC 1 0 02-06-14 10-06-14
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8 1 0 0 0 0 0 1 0 PROBABLE OP POISONING 150 18 76/50 91 INTUBATED 1 0 2 1 3 3 2
7 1 0 0 0 0 0 0 0 OP POISONING CHLORPYRIPHOS CYPERMETHRIN120 24 130/70 97 1 1 1 1 2 2 2
11 1 0 1 0 0 1 ON AUGMENTIN AND AZITHROMYCIN FOR 2 DAYS PRESCRIBED IN OPD 1 0 ACUTE PULMONARY EDEMA 132 32 210/110 86 1 1 2 1 2 2 1
1 1 1 0 0 1 OFLOX 0 SCRUB TYPHUS 113 24 140/60 95 1 1 1 1 1 1  
6 3 0 0 0 0 0 3 1 ACUTE FEBRILE ILLNESS 108 30 153/77 97 1 1 1 1 3 3 3
8 1 0 0 0 0 0 0 0 ?ALCOHOL WITHDRAWAL/METABOLIC ENCEPHAOPATHY103 40 128/70 88 2 1 1 1 3 3 2
5 3 1 1 1 0 0 1 0 ACUTE FEBRILE ILLNESS 96 30 130/80 90 3 1 2 2 1 1 3
3 1 0 0 0 0 0 1 1 CARBAPHOS POISONING124 20 110/60 93 1 1 1 1 2 3 3
4 3 0 0 0 0 1 0 0 NITROBENZENE POISONING114 INTUBATED110/70 94    1 2 2 2 3
3 3 0 1 0 0 0 0 1 ACUTE FEBRILE ILLNESS 118 24 80/60 95 1 1 1 2 2 2 3
7 3 1 0 0 0 1 0 0 ACUTE FEBRILE ILLNESS 101 60 99/64 78 1 1 1 1 2 2 3
6 3 1 0 0 0 0 0 1 DIABETIC KETOACIDOSIS ACUTE GASTROENTERITIS110 20 100/60 75 1 1 2 2 2 2 3
8 3 1 1 0 1 0 3 0 EXACERBATION OF COPD100 32 140/80 85 1 1 2 1 2 2 1
10 2 0 0 0 0 0 7 0 OP POISONING CHLORPYRIPHOS86 12 140/77 99 1 1 1 2 1 1 1
7 3 0 0 0 0 0 1 0 OP POISONING QUINALPHOS 140 26 160/90 95 1 1 1 1 2 2 1
11 1 1 1 0 0 0 1 0 OP POISONING PHPRATE100 30 250/110 56 1 1 1 1 2 2 3
4 1 0 0 0 0 0 0 0 PARTIAL HANGING / POPE 120 28 120/80 90 1 1 2 1 2 2 1
6 1 1 0 0 0 0 0 1 ACUTE FEBRILE ILLNESS 104 24 80/60 93 1 0 2 1 3 3 2
8 1 0 0 0 0 0 0 0 OP POISONING NEONICOTINOID 106 BAGGING 100/80 100 1 1 2 2 2 2 3
5 1 0 0 0 0 0 1 0 PHORATE POISONING 112 26 100/70 97 1 1 2 2 1 1 2
3 1 0 1 0 0 0 1 0 LEFT LEG CELLULITIS AKI 105 22 127/57 83 1 1 1 1 3 2 1
2 1 1 1 0 0 1 0 0 EXACERBATION OF COPD148 27 120/70 80 1 1 1 1 3 3 3
6 3 0 1 0 0 0 1 1 COMMUNITY ACQUIRED PNEUMONIA 101 48 160/90 80 1 1 1 2 3 3 3
8 1 0 1 0 0 0 4 0 SCLERODERMA ILD 114 BAGGING 128/88 99 INTUBATED 1 0 2 1 2 2 3
5 1 0 0 0 0 0 0 1 OP POISONING ETHION D21 1 25 103/60 80 ESOPHAGEAL INTUBATION- -SHIFTEC FROM OTHER HOSP5 1 1 2 1 1 2
5 3 0 0 0 0 0 8 1 OP POISONING ETHYL PARATHION DOPE180 18 130/70 88% 1 1 1 1 2 2 1
5 3 0 0 0 0 1 STREPTOMYCIN/CEFTRIAXONE/ATT3 1 TUBERCULOUS MENINGITIS141 20 124/74 99 1 1 1 1 2 2  
6 1 1 0 0 1 0 2 1 COMMUNITY ACQUIRED PNEUMONIA96 36 130/80 85 2 1 1 2 1 1 2
4 1 0 0 0 0 0 13 1 ACUTE PULMONARY EDEMA 130 BAGGING 143/109 99 INTUBATED 1 1 2 2 2 2 3
9 1 1 1 0 0 0 0 0 CARDIOGENIC SHOCK 124 34 160/100 96 1 1 2 1 2 2 2
8 1 0 1 1 0 0 1 1 AFI ?UROSEPSIS 126 40 120/80 99 4 1 1 2 2 2 3
4 1 1 1 1 0 0 1 0 DILATED CARDIOMYOPATHY80 26 60 SYSTOLIC 95 1 1 1 1 1 1 2
9 3 1 1 0 0 0 0 1 HONC/UTI 90 20 90/60 94 1 0 1 1 2 2 2
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2 0 0 1  1 3 1 2 1 5 0 1 13 13 1 2 42
2 0 0 1 0 0 0  1 1 7 1 1 24 24 1 2 35
1 0 0 0  0 0 1 1 1 3 0 0 19 19 0 2 62
1 0 0 0 0 0 0 0 0 0 4 6 0 1 61
1 0 0 0 0 0 0 0 0 0 13 15 0 1 40
1 0 0 1  1 3 0 0 1 10 16 0 1 51
1 0 0 0 0 0 0 1 1 1 5 0 0 7 11 0 1 76
1 0 0 0  0 0 1 1 1 4 0 0 4 7 0 1 21
1 0 0 0  0 0 0 0 0 5 7 0 1 20
1 0 0 0 0 0 0 0 0 0 3 10 0 1 64
2 0 0 1 0 1 3 1 1 1 14 0 1 14 14 0 2 71
2 0 0 1 0 0 0 1 1 1 6 1 1 9 27 0 1 40
1 0 0 0 0 0 0 0 0 0 5 23 0 1 76
1+2 0 0 1 0 0 0 0 1 1 20 32 1 1 56
1 0 0 0 0 0 0 0 0 0 21 29 1 1 24
1 0 0 1 0 0 0 0 0 0 22 26 1 1 64
1 0 0 0 0 0 0 0 0 0 4 5 0 1 23
1 0 0 1 0 1 1+2 0 0 0 6 0 0 6 7 0 1 18
1 0 0 0 0 0 0 0 0 14 17 1 1 21
1 0 0 0 0 0 0 0 0 0 5 8 0 1 19
1 0 0 0 0 0 0 0 0 0 4 7 0 1 71
5 0 0 0 0 0 0 1 1 1 2 0 0 2 2 0 1 66
1 0 0   0 0 1 1 1 3 0 0 7 12 0 2 61
2 0 0 0 0 0 0  0 0 26 26 1 2 61
2 0 0 1 1 1 3 1 1 1 NR 0 0 18 19 1 2 49
1+2 0 0 1  0 0 0 0 0 0 1 5 18 1 1 30
3 0 0 1 0 0 0 0 NA NA 0 0 6 13 0 2 20
1 0 0 1 0 0 0 0 0 0 8 19 1 DAMA 78
1 0 0 1 0 0 0 0 0 1 24 29 0 1 24
1 0 0 0 0 1 1 1 1 1 0 0 6 14 0 2 66
1 0 0 0 0 0 0 0 0 0 11 19 0 1 61
1 0 0 0 0 0 1 0 0 0 4 14 0 1 48
2 0 1 1 0 0 1 0 0 0 10 16 0 1 62
MEDICINE 1 18 1 2 CEREBROVASCULAR ACCIDENT / RIGHT THALAMIC BLEED 1 0 0 29-03-14 03-04-14
MEDICINE 1 10 1 1 OP POISONING / TRIAZOPHOS AND DELTAMETHRIN / ALCOHOLIC HEPATITIS / VENTILATOR ASSOCIATED PNEUMONIA 1 0 0 22-03-14 28-03-14
MEDICINE 2 27 2 2 COMMUNITY ACQUIRED PNEUMONIA / SEPTIC SHOCK / ACUTE KIDNEY INJURY / NOSOCOMIAL URINARY TRACT INFECTION / CRITICAL ILLNESS POLYNEUROPATHY1 370 E COLI / ENTEROCOCCUS / CONS29-12-13 04-01-14
MEDICINE 4 20 1 2 PYELONEPHRITIS / LEFT HYDROURETERONEPHROSIS / CHRONIC ACTIVE HEPATITIS B INFECTION / DEFORMED PYLORODUODENAL COMPLEX1 120 NFGNB 03-01-14 07-01-14
MEDICINE 1 22 1 1
ATRIAL FIBRILLATION
LOWER GI BLEED
ACUTE INFECTIVE EXACERBATION OF COPD
VENTILLATOR ASSOCIATED PNEUMONIA
DIABETES MELLITUS
ACUTE ON CHRONIC KIDNEY DISEASE
ANEMIA
METABOLIC ACIDOSIS / HYPERKALEMIA
SEPTIC SHOCK 1 0 0 18-12-13 02-01-14
MEDICINE 3 20 1 2 DENGUE/VAP/AGE CHOLERA 2 300 NFGNB RESISTANT TO 11-06-14 16-06-14
MEDICINE 4 19 1 1 PROBABLE TUBERCULOUS MENINGITIS / ASPIRATION PNEUMONIA 2 1 1 15-06-14 16-06-14
MEDICINE 2 33 1 2 UROSEPSIS WITH E COLI BACTEREMIA / PROBABLE NOSOCOMIAL PNEUMONIA / CENTRAL PONTINE INFARCT / HONC / LEFT LOWER LIMB DVT  1 0 10-06-14 17-06-14
MEDICINE 1 26 2 1 PYREXIA OF UNLNOWN ORIGIN SEE D/S 1 1000 / 50 NFGNB / ENTEROCOCCUS13-06-14 21-06-14
MEDICINE 3 12 1 1 RIGHT PARIETO OCCIPETAL BLEED WITH INTRAVENTRICULAR EXTENSION YPUNG HYPERTENSIVE NO SECONDARY CAUSE 1 0 29-10-13 02-11-13
MEDICINE 4 20 1 2
DISSEMINATED TUBERCULOSIS
IMMUNE MEDIATED POLYNEUROPATHY WITH SENSORY MOTOR 
AXONOPATHY
PROABABLE SYSTEMIC VASCULITIS
ANEMIA OF CHRONIC DISEASE
STEROID INDUCED DIABETES MELLITUS
SEIZURE DISORDER 1 0 19-06-14 26-06-14
MEDICINE 3 27 1 2 ACUTE INTERMITTENT PORPHYRIA / ASPIRATION PNEUMONIA 1 0 14-Jun 23-06-14
PULM MED 31 1 1
CHRONIC OBSTRUCTIVE PULMONARY DISEASE /  NSTEMI / OBSTRUCTIVE 
SLEEP APNOEA/
PROBABLE OBESITY HYPOVENTILLATION SYNDROME 1 0 19-02-14 24-02-14
100 NFGNB
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6 1 0 1 0 0 0 0 0 CEREBROVASCULAR ACCIDENT RIGHT THALAMIC BLEED80 26 160/100 90 1 1 1 1 3 3 1
7 1 0 0 0 0 0 8 1 TRIAZOPHOS AND DELTAMETHRIN POISONING86 24 120/80 88 1 1 1 1 2 2 3
7 1 0 0 0 0 0 0 1 COMMUNITY ACQUIRED PNEUMONIA70 32 60/40 80    1 1 2 2 3
5 1 0 0 0 0 0 2 1 ACUTE FEBRILE ILLNESS 110 30 98/60 84    1 1 2 2 3
15 1 1 0 1 1 0 2 1 ATRIAL FIBRILLATION 104 40 140/90 88 1 1 1 1 2 2 2
6 1 1 1 0 0 0 5 1 AFI/DELIRIUM TREMENS/?WERNICKES ENCEPHALOPATHY110 NR 60 SYSTO ICNR 1 1 1 1 1 1 2
3 0 0 0 0 1 1 MENINGITIS 180 44 130/80 88 2 1 1 1 2 1  
8 3 1 0 0 0 0 6 1 UROSEPSIS HYPERNATREMIA126 38 130/80 88 1 1 1 2 1 1 2
9 3 0 0 0 0 0 1 1 PYREXIA OF UNKNOWN ORIGIN / ANAPHYLACTIC REACTION VITAMIN K INJECTION110 22 110/70 100 1 1 1 1 2 2 2
5 1 0 1 0 0 0 2 0 CVA  92 16 210/150 99 1 1 1 1 2 1 2
8 1 0 0 0 0 1 45 1 PERIPHERAL NEUROPATHY . PULMONARY TUBERCULOSIS148 68 130/80 96 ON 6L O2 1 1 1 1 2 2 2
10 2 0 0 0 0 0 3 1 SEIZURES UNDER EVALUATION110 40 110/70 88 1 1 1 1 1 1 2
6 1 1 1 0 1 0 0 0 ACUTE EXACERBATION OF COPD106 46 180/110 62 1 1 2 1 2 2 1
1 0 0 0 0 0 0 1 1 1 6 0 0 11 9 1 2 76
2 0 0 1 0 1 3 1 1 1 7 0 0 17 35 1 1 66
2 0 1 1 0 1 3 1 1 1 8 0 1 15 25 1 1 49
1 0 0 0 0 0 0 1 1 1 7 0 0 20 5 0 1 53
2 0 0 1 0 0 0 1 1 1 6 0 0 59 59 0 1 68
1+2 0 0 1 0  0 0 1 11 17 0 1 58
2 0 0 1 0 0 0 0 0 1 10 12 0 1 23
1 0 0 0 0 1 3 1 1 1 5 0 0 14 14 1 2 56
1 0 0 0 0 0 0 0 0 1 8 18 0 1 16
1 0 0 0 0 0 0 1 1 1 3 0 0 3 9 0 1 43
1 0 0 0 0 0 0 0 0 0 0 0 0 34 72 0 1 57
1 0 0 1 0 0 0 0 0 0 6 21 1 1 25
1 0 0 0   NR 0 0 0 6 11 0 2 67
. 
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CODE REASON FOR CVC REMOVAL
NO LONGER REQUIRED 1
MHDU 1 CRI SUSPECTED 2
MICU 2 PATIENT HAS EXPIRED 3
CVC RELATED (MECH ) COMP 4
SEX DAMA /DISCHARGE AT REQUEST 5
male 1 WRONG LOCATION/ MALPOSITION 6
Female 2
IMMEDIATE COMPLICATIONS OF CVC INSERTION
INDICATION : PNEUMOTHORAX 1
HEMODYNAMIC INSTABILITY 1 HEMOTHORAX 2
LACK OF PERIPHERAL VENOUS ACCESS 2 HEMATOMA 3
ANTICIPATE WORSENING 3 ARTERIAL PUNCTURE 4
more than 1 indication 4 dvt 5
hemo. Inst. And NaHCO3 5
PRE EXISTING MEDICAL CONDITIONS LOCAL EXAMINATION 
DM YES = 1 NO=0 REDNESS 1
HTN YES = 1 NO=0 WARMTH 2
CKD YES = 1 NO=0 TENDERNESS 3
COPD YES = 1 NO=0 PURULENT DISCHARGE 4
SITE FEVER FROM CVC INSERTION TO REMOVAL
IJV 1 YES = 1 NO = 0
FEMORAL 2
DID THE PT HAVE HYPOTENSION FROM INSERTION TO REMOVAL
SIDE 
RIGHT 1 YES = 1 
LEFT 2 NO = 0
HAS THE PATIENT RECEIVED ANTIBOTICS BEFORE ADMISSION IF YES THEN DID HE REQUIRE 
FLUIDS 1
YES = 1 INOTROPES 2
NO = 0 BOTH 3
DOES THE PATIENT HAVE FEVER AT THE TIME OF CVC INSERTION (TEMP >101) CHILLS YES = 1 
YES = 1 NO = 0
NO = 0
OTHER EVIDENT SOURCE OF INFECTION:
OPERATOR FACTORS SPUTUM YES = 1 NO = 0 sputum YES = 1 NO = 0 not done = 2
ULTRASOUND GUIDANCE URINE YES = 1 NO = 0 urine YES = 1 NO = 0 not done = 2
YES = 1
NO = 0 COLLECTION/ABSCESSYES = 1 NO = 0
arterial line side art line
PLACE OF CVC INSERTION POSITIVE CULTURE S YES = 1 NO = 0 right = 1 right 
MHDU 1 left = 2 
MICU 2 ART LINE YES = 1 NO = 0 none = 0
SITE RADIAL = 1
INSERTED BY FEMORAL = 2
REGISTRAR 1
INTERN 2 ALIVE 1
CONSULTANT 3 DIED 2
TOTAL NO OF CVC INSERTED BY THE OPERATOR :
. 
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DIAGNOSIS
<10 1 low
10 TO 30 2 intermediate OP POISONING 1
> 30 3 high PNEUMONIA 2
PYELONEPHRITIS 3
CVC S AT THIS SITE operator experience SEPTIC SHOCH 4
<5 1 LOW CARDIOGENIC SHOCK / DCMY 5
5 TO 15 2 INTERMEDIATE PULMONARY TUBERCULOSIS 6
> 15 3 HIGH TUBERCULOUS MENINGITIS 7
GI BLEED 8
SCRUB TYPHUS 9
MORNING SHIFT 1 HANGING 10
EVENING SHIFT 2 CHRONIC KIDNEY DISEASE 11
NIGHT SHIFT 3 MENINGOENCEPHALITIS 12
AMITRYPTILENE OVERDOSE 13
CARBAMAZEPINE OVERDOSE 14
MYAESTHENIA GRAVIS 15
VARICEAL BLEED 16
ODUVANTHALAI POISONING 17
SNAKE BITE 18
CVA 19
INFECTIVE ENDOCARDITIS 20
NECROTIZING FASCITIS 21
STATUS EPILEPTICUS 22
ACUTE EXACERBATION OF COPD 23
CHROMIUM INTOXICATION 24
CNS VASCULITIS 25
HYPONATREMIA 26
PORPYRIA 27
DISSEMINATED TUBERCULOSIS 28
AFI 29
DENGUE 30
PRE ECLAMPSIA 31
ACS 32
CELLULITIS 33
ATRIAL FIBRILLATION 34
ALCOHOL INTOXICATION 35
HYPOGLYCEMIA 36
NITROBENZENE POISONING 37
PULMONARY EDEMA 38
HEPATIC ENCEPHALOPATHY 39
SLE 40
CERVICAL MYELOPATHY 41
CORROSIVE INJURY
. 
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